Documente Academic
Documente Profesional
Documente Cultură
24
ductului limfatic toracic au fost examinate prin prepararea anatomic i aplicarea metodelor
antropometrice. Toate preparatele au fost fotografiate cu camera digital.
Rezultatele i discuii
Conform noiunii, arcul aortic (ArA) este segmentul aortei localizat ntre originea
trunchiului brahiocefalic i artera subclavicular stng.
Numrul i ordinea pornirii ramurilor lui sunt foarte
variabile. Acest fapt se explic prin embriogeneza
complex. Arcul aortic poate fi brusc curbat sau uor
curbat. n cel dinti caz, toate ramurile lui pornesc de
la un sector mai scurt dect n situaia de curb
aplatisat. Dispersarea ramurilor n arcul plat curbat
trebuie se fie luat n eviden n timpul efecturii
aortografiei transcarotide. Lungimea medie a arcului
aortic este de 4,3 cm. La maturi, cel mai scurt arc
observat de noi era de 2,7 cm, iar cel mai lung - de
6.0 cm.
Studiile sintopiei organelor mediastinului superior pe
98 de preparate au demonstrat variabilitatea larg a
Fig.1. Arcul aortic brusc curbat.
corelaiilor interorganice i a traiectului nervilor i al
1 trunchiul brahiocefalic; 2
vaselor adiacente. Acest fapt are o importana
artera carotid comun stng; 3
practic deosebit. Atenie special a fost acordat
artera subclavicular stng; 4
momentelor eseniale pentru vizualizarea mai rapid
artera pulmonar dreapt; 5 traheea;
a nervilor n discuie pe parcursul interveniilor
6 ezofagul; 7 nervul vag stng; 8
chirurgicale. Pe de o parte, o asemenea abordare
ductul arterial; 9 devierea atipic
contribuie la profilaxia traumrii nervilor, iar de pe
a nervului recurent stng; 10 nodul
alt parte, dac aceasta a avut loc, la alegerea
limfatic; 11 - nervul recurent stng.
variantei
mai
potrivite
a
tehnicii
neuromicrochirurgicale, n cazul efectuarii reinervaiei. Problema traumrii nervilor vag i cel
laringean din stnga provoac discuii largi n rndul clinicienilor [4,6,8].
n linii generale, am obinut rezultate similare, ce se refer la organele adiacente arcului
aortic, altor autori:
- anterior, arcul aortei este acoperit de pleura, de marginile anterioare ale plmnilor i de
timus;
- n partea anteromedial a nervului vag este situat nervul frenic stng, n cea anterosuperioar a
arcului aortei - vena brahiocefalic stng;
- mai jos de arcul aortei se afl artera pulmonar stng i bronhul stng; intersectndu-le,
arcul aortic urmeaz n poriunea descendent;
- pe semicircumferina anteroinferioar a arcului aortei se insereaz ligamentul arterial - ductul
arterial (Botall) obliterat;
- n partea posterioar a arcului aortei se situeaz traheea, esofagul, ductul limfatic toracic;
- de la suprafaa superioar a arcului aortic n direcie cranian i iau nceputul trunchiul
brahiocefalic, artera carotid comun stng i artera subclavicular stng;
- din dreapta se localizeaz poriunea ncepient a venei cave superioare;
- din toate prile arcul aortic este nconjurat de ramurile trunchiurilor simpatice i ale nervilor
vagi, ce formeaz plexul cardiac.
Mai e de completat unele raporturi interorganice, ce au importan practic. Poriunea
mijlocie a arcului nu este acoperit de pleura, ceea ce e utilizat de medici la efectuarea anesteziei
retrosternale a plexului cardiac. ntre nervul frenic i nervul vag trece vena intercostal suprema
stng, avnd o direcie oblic anterosuperioar, iar sub arc se localizeaz 4-6 noduli limfatici cu
mrimea de 0,5-1.0 cm. n interiorul toracelui nervul recurent stng se afl n contact strns cu
aorta, cu traheea, cu atriul stng, cu bronhul principal stng, cu esofagul i cu noduli limfatici.
28
Fiind n contact strns cu diferite structuri anatomice, nervul vag i cel recurent laringean stngi
sunt extrem de vulnerabili att n condiiile lor patologice, cum ar fi aneurismele aortale,
dilatrile atriului stng n stenoza mitral sau aortic, tumorile mediastinale, ale bronhiilor
principali i ale plmnului stng, ct i n timpul interveniilor chirurgicale. Localizarea
nervului recurent stng n contact direct cu artera pulmonar necesit o atenie deosebit n
timpul ligaturrii i seciunii acestui vas. Disecia efectuat ntre trahee i aort cauzeaz tracia
nervului recurent stng, dereglrile frecvente ale nervului laringean n timpul mediastinoscopiei
se explic prin acest mecanism de leziune indirect. In cazul unor traumatisme intratoracice sau a
tumorilor, cel mai des sunt lezati nervii recureni, mai ales cel de pe partea stng.
Clinicienii evideniaz trei zone ce se refer la riscul de deteriorare
a nervului recurent stng:
a) zona de risc sczut de-a lungul peretelui drept i naintea poriunii superioare a peretelui
anterior al traheei;
b) zona de risc nalt a leziunilor indirecte induse de compresiuni - ntre partea inferioar a
peretelui traheei i aorta;
c) zona de risc ridicat de vtmare direct - naintea poriunii inferioare a peretelui stng al
traheei.
Rezultatele cercetrii noastre ne piermit completarea informaiei urmtoare din sursele
bibliografice: nervul vag stng intersecteaz arcul
aortei n partea anterioar, ramura lui - nervul
recurent laringean - l ocoleste inferior, lng
ligamentul arterial, apoi posterior i trece prin
anul traheoezofagian anterior. Astfel, traiectul
nervului vag stng pe faa anterioar a arcului
variaz de la cel pracic vertical la oblic, sub
unghiul ascuit fa de planul orizontal (Figg.2,4).
Distana ntre nervul recurent i ligamentul arterial
la fel variaz de la contact strns pn la 1.0 cm;
iar
localizarea
acestui
nerv
n
anul
traheoezofagian se atest numai n 58% de cazuri .
n descrierile clasice nervul vag stng trece
anterior de poriunea incipient a arterei
subclaviculare stngi i intersecteaz faa
Fig.2. Arcul aortic uor curbat cu
anterioar a poriunii stngi a arcului aortic.
cinci ramuri.
Dup rezultatele cercetrii noastre n 46% se atest
1 trunchiul brahiocefalic; 2 artera
alte raporturi: n 32% nervul trece lateral pn la
carotid comun dreapt; 3 arteria
2,5 cm; n alte cazuri mai medial (Figg.2,3,4).
tiroida ima; 4 artera carotid comun
n literatura de specialitate sunt multe descrieri ale
stng; 5 artera subclavicul stng; 6
traiectului anomalos ale nervului vag stng i a
nervul vag stng; 7 - nervul recurent
celui recurent [1,2,7].
stng; 8 ductul arterial.
N-a fost depistat proporionalitatea direct ntre
lungimea arcului i a tipului constituional, ntre
numrul de ramuri i lungimea arcului.
Nu exist legiti referitoare la corelaiile neurovasculare n situaii cu un numr divers de
ramuri ale arcului. Deci localizarea lateral a nervului vag a fost atestat la arcuri cu 3 i 5
ramuri, iar cea medial, n cazul de patru ramuri (Figg.1,2,4). Nici numrul de ramuri nu depinde
de forma i de lungimea arcului. Aadar, trei ramuri au fost constatate la arcurile aortice cu o
lungime de la 2,7 pn la 5,0 cm; patru ramuri la arcuri cu o lungime de la 4,2 pn la 6,0 cm.
Au fost constatate arcuri de 5 cm lungime doar cu dou ramuri i de 5,7 cm cu cinci (Figg.2,3).
Este evident, corelaiile nervilor adiaceni arcului nu pot fi similare n diferite cazuri.
29
n regiunea gtului riscul traumrii nervului vag stng este mai mare dect al celui drept,
din cauza particularitilor de corelare cu artera tiroid inferioar. n regiunea toracelui mai
frecvent are loc traumarea nervului laringean stng.
n 88 % de cazuri nervul recurent stng pornete de la suprafaa dorsomedial a nervului
vag, n 12% - de la cea medial, pe faa anterioar a arcului. n poriunea iniial, sub arcul
aortei, posterior de triungiul Gross, el
contacteaz strns cu 3-5 ganglioni limfatici
de dimensiuni mari (0.5-1.0 cm). La acest
nivel nervul recurent repet configuraia lor,
iar n caz de creterea lor n dimensiuni, se
aplatiseaz esenial, devenind de 2-3 mai
subire dect iniial. Acest fapt poate duce la
modificri fonetice, greu diagnosticabile din
partea laringelui.
n 10 % de cazuri, nervul recurent este
reprezentat de dou sau trei trunchiuri.
Conform datelor lui C.Weeks, J.Hinton
Fig.3. Arcul aortic uor curbat cu dou
(1942), acest fenomen este ntlnit n 78%
ramuri.
de cazuri; n conformite cu observaiile pe
1 originea comun a trunchiului
cini ce aparin lui Iakovleva I.A. (1966) n
brahiocefalic cu artera carotid comun stng;
25%.
2 trunchiul brahiocefalic; 3 artera carotid
Este evident distribuirea lor permanent n
comun stng; 4 artera subclavicular
plan frontal unul fa de altul. Distana
stng; 5 nervul vag stng; 6 traheea; 7 dintre trunchiuri pe faa posterioar a
nervul recurent stng; 8 ductul arterial; 9
poriunii concave a arcului aortal variaz de
originea tipic a nervului recurent; 10 nodul
la 2 mm pn la 5 mm, ns la nivelui feei
limfatic.
ei convexe 10-14 mm (fig.4 ).
Un interes practic prezint faptul c toate cazurile
de trunchiuri supranumerare au fost observate la
persoanele de tip constituional brahimorf. n
diferite surse de literatur didactic se descrie
divizarea nervului recurent laringean n dou
ramuri (medial i lateral) la nivelul limitei
inferioare a laringelui. Probabil, existena mai
multor trunchiuri ale nervului recurent se poate
explica prin divizarea lui inferioar.
Am observat o legitate: trunchiurile supranumerare
ale nervului recurent stng se depisteaz n cazuri
n care nervul vag stng intersecteaz marginea
convex a arcului aortic n aproximitatea originii lui
Fig.4. Arcul aortic plat curbat cu
(fig. 4). Aadar, pe baza vizualizrii intraoperatorii
patru ramuri.
a nervului vag se poate prognoza topografia
1 trunchiul brahiocefalic; 2 artera
individual a nervului recurent stng, ce la rndul
carotid comun stng; 3 artera
su permite diminuarea riscului de traumare a
vertebral stng; 4 artera
ultimului.
subclavicular stng; 5 traiectul
n studiul nostru au fost depistate variantele
atipic al nervului vag stng; 6
ramificrii arcului aortic i ale inseriei
traheea; 7 trunchiurile nervului
ligamentului arterial, traiectele atipice ale nervului
recurent stng; 8 ezofag; 9 ductul
vag stng i ale nervului recurent, existena
arterial.
trunchiurilor supranumerare ale ultimului, prezena
ductului toracic limfatic dublu.
30
31
matriceale), n special MMP9 [5, 8,]. n mai multe tumori infiltraia cu TAM coreleaz pozitiv cu
proliferarea tumoral, estimat prin MIB-1, Ki67 sau indicele mitotic [8]. Acest lucru se explic
prin faptul c TAM elimin mai muli factori care stimuleaz proliferare i supravieuirea
celulelor tumorale. Printre aceti factori pot fi menionai EGF (epidermal growth factor), PDGF
(plateled-derived growth factor), VEGF (vascular endothelial growth factor), HGF (hepatocyte
growth factor) i bFGF (basic fibroblast growth factor) [9].
Majoritatea autorilor coreleaz numrul mare de macrofage n tumori cu un prognostic
nefavorabil [8]. n literatura de specialitate exist puine date despre rolul macrofagelor n
neoplazia de col uterin. Conform Kobayashi A. i col (2008), densitatea macrofagelor CD68
pozitive crete pe msura sporirii severitii neoplaziei, iar expresia MMP-9 de ctre aceste
celule este maximal n CIN3 (neoplazie cervical intraepitelial) [5]. Davidson B. i col (1999)
susin c densitatea macrofagelor nu coreleaz cu supravieuirea n cancerul cervical [1], iar
Gonalves M.A. i Donadi E.A. (2004) afirm c prezena macrofagelor ar putea fi un indicator
al regresiei leziunii [4].
Material i metode
Specimenele i procesarea primar. n studiul prezent au fost prelevate i incluse biopsiile
intite din leziuni evidente macroscopic, materialul postoperator i piesele de conizaie.
Materialul colectat a fort prelucrat dup tehnica histologic uzual, fixat n formalin i
incluzionat n parafin.
Histopatologie. Din fiecare bloc au fost efectuate seciuni n serii cu grosimea de 3 m
grosime. Seciunile iniiale au fost colorate cu metoda hematoxilin-eozin pentru diagnosticul
patologic i stabilirea gradului de difereniere al tumorii. Leziunile au fost clasificate dup cum
urmeaz: CIN1 (neoplazie cervical intraepitealial 1) (n=17), CIN2 (n=11), CIN3 (n=7),
carcinom microinvaziv (n=10) i carcinom invaziv (n=49). Cazurile control (n=5) au fost
reprezentate de specimenele normale rezultate n urma procedurii de biopsie.
Imunohistochimie. Pentru evidenierea macrofagelor, am recurs la coloraia seciunilor cu
anticorpul primar monoclonal anti-CD68, clona PG-M1, RTU, DakoCytomation (Danemarca).
Demascarea antigenului a a fost efectuat prin digestie enzimatic. Sistemul de lucru compatibil
a fost cel de tip LSAB2, iar cromogenul aplicat 3,3 diaminobenzidina dihidroclorid, vizualizat
printr-o reacie de culoare brun. Nucleii au fost colorai cu hematoxilin Lille modificat.
Montarea s-a realizat n mediu de montare permanent (balsam de Canada). ntreaga procedur
imunohistochimic a fost executat cu ajutorul DakoCytomation Autostainer. Drept control
pozitiv intern au fost considerate macrofagele CD-68 pozitive.
Metoda de cuantificare hot spot. este cea mai utilizat metod manual de cuantificare a
structurilor histologice. La microscopul optic ariile de cuantificare se aleg la o mrire 200, ceea
ce corespunde suprafeii de 0,74 mm2. Metoda const n alegerea a trei zone cu densitatea cea
mai mare a macrofagelor, numrarea fiind urmat de calcularea mediei aritmetice.
Analiza statistic. A fost efectuat cu programul SPSS13-0, i a inclus testul Chi ptrat i
testul Student, valorile p<0.05, fiind considerate semnificative.
Rezultate
Specificitatea imunocolorrii anti-CD68. Produsul final de reacie pentru CD36,
macrofagele, s-au colorat n brun cu DAB. Reacia a fost exprimat la nivelul citoplasmei cu
pattern difuz.
Distribuia macrofagelor CD68 pozitive n cervixul uterin normal. n specimenele normale
macrofagele erau prezente n stroma subepitelial, mai ales n profunzimea ei, fiind mai puine n
epiteliul stratificat scuamos (Tab. 1). Numrul macrofagelor CD68 pozitive sporea n cazul
infiltratelor limfo-histiocitare subepiteliale.
Macrofagele CD68 pozitive n leziunile precursoare. n CIN1, distribuia macrofagelor
CD68 pozitive nu se deosebea de cervixul uterin normal, se constata doar o uoar cretere a
densitii acestora. n CIN2, numrul macrofagelor era mai mare, mai ales pe contul infiltrrii
33
epiteliului neoplazic (Tab. 1). Macrofagele intraepiteliale CD68 pozitive erau de dimensiuni mai
mari i infiltrau toate straturile epiteliului scuamos, fiind mai puine totui n stratul superficial.
n strom, macrofagele CD68 pozitive erau localizate mai frecvent la interfaa cu epiteliul
stratificat scuamos, adernd intim la membrana bazal a acestuia, de asemenea n apropierea
vaselor sanguine. O distribuie similar a macrofagelor a fost observat i n cazurile cu CIN3,
doar c a fost observat o cretere a densitii macrofagelor CD68 pozitive n profunzimea
epiteliului neoplazic (Tab. 1-3).
Tabelul 1
Densitatea macrofagelor CD68+ intra- i periepiteliale n cadrul progresiei
neoplaziei de col uterin
Macrofage CD68+
periepiteliale
Macrofage CD68+
intraepiteliale
Cazuri
control
(norm)
106,64,9
n=5
51,25,1
n=5
CIN1
CIN2
CIN3
118,95,5
n=17
56,53,6
n=17
125,88,8
n=11
78,55,2
n=11
123,012,1
n=7
104,08,0
n=7
Carcinom
microinvaziv
309,121,1
n=10
207,117,8
n=10
Carcinom
invaziv
405,111,3
n=49
194,36,4
n=49
Tabelul 2
Compararea densitii macrofagelor intraepiteliale CD68+ dintre cazurile control, CIN1-3,
carcinom microinvaziv scuamocelular i carcinom invaziv scuamocelular al colului uterin
Diagnosticul histologic
Control, CIN1
Control, CIN2
Control, CIN3
Control, Carcinom microinvaziv
Control, Carcinom invaziv
CIN1, CIN2
CIN1, CIN3
CIN1, Carcinom microinvaziv
CIN1, Carcinom invaziv
CIN2, CIN3
CIN2, Carcinom microinvaziv
CIN2, Carcinom invaziv
CIN3, Carcinom microinvaziv
CIN3, Carcinom invaziv
Carcinom microinvaziv, Carcinom invaziv
t
2,19
9,84
13,94
25,71
58,37
12,16
15,08
26,48
109,56
7,49
22,04
63,66
16,15
28,60
2,25
p
<0.05
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.05
p
<0.001
<0.001
<0.01
<0.001
<0.001
<0.05
1*
<0.001
<0.001
1*
<0.001
<0.001
<0.001
<0.001
<0.001
Discuii
Componentul inflamator al neoplaziei include o populaie celular divers: macrofage,
limfocite, neutrofile, eozinofile i mastocite. Infiltrarea leucocitelor n focarul neoplazic poate fi
privit sub aspect de rspuns antitumoral. Exist, ins, multe studii convingtoare care pun n
eviden c limfocitele i macrofagele recrutare din patul microcirculator n focarul neoplazic
reprezint sursa major de citokine proinflamatorii, factori de proliferare i factori angiogenici.
Compoziia, distribuia i numrul limfocitelor ce infiltreaz tumoarea pot avea impact asupra
diagnosticului, pronosticului i tratamentul pacienilor cu maladie oncologic.
Macrofagele, prin prisma spectrului su funcional, sunt celule universale ale organismului,
cu o vdit heterogenitate. Aceast heterogenitate apare n timpul diferenierii lor din precursorii
monocitari i este determinat de stimuli genetici, tisulari, imuni. n aceast ordine de idei,
antigenele microbiene, produii tumorali, complexele imune influeneaz heterogenitatea i
statutul de activare al acestor celule. Sub aciunea moleculelor microbiene, celulelor canceroase,
citokinelor
macrofagele
rspund
prin
sinteza
substanelor
proinflamatorii/microbicide/tumoricide. Acest rspuns poart denumirea de activare clasic i
se realizeaz cnd asupra lor acioneaz interferonul- (IFN), TNF, acidul lipotecoic,
proteinele ocului hipertermic, componentele ECM. Macrofagele rezultate n urma activrii
clasice (M1) i produii lor joac un rol important n aprarea contra patogenilor intracelulari, iar
n anumite condiii i contra celulelor tumorale. M1, de obicei, produc cantiti mari de IL-12 i
IL-23 i cantiti mici de IL-10. De asemenea sunt promotori puternici ai rspunsului imun TH1
mediat (Limfocitele T-helper subgrupa 1), manifest o activitate antiproliferativ i citotoxic,
datorit abilitii lor de a secreta compui azotai reactivi, NO, peroxid de hidrogen, superoxid,
ct i citokinelor proinflamatorii (TNF, IL-1, IL-6) [11].
Datele noastre vin s confirme multe alte studii similare vis-a-vis de distribuia TAM.
TAM se situeaz sub membrana bazal a epiteliului neoplazic, n zona de invazie tumoral, n
jurul vaselor microcirculaiei, n ariile stromale hipoxice i perinecrotice a tumorii. De rnd cu
35
fibroblastele TAM sunt apte de a secreta intens MMP [14], respectiv de a degrada matricea
extracelular (ECM) n cadrul invaziei tumorale. Hipoxia inhib migrarea macrofagelor, astfel
TAM sunt imobilizate n ariile hipooxigenate ale tumorii [6]. Hipoxia supreseaz activitatea
antitumoral a TAM, abilitatea de a fagocita celulele moarte i a prezenta antigenul limfocitelor
T, reduc sinteza a TNF- [8]. Migrarea TAM n zonele hipoxice/necrotice este extrem de
important pentru supravieuirea celulelor tumorale, care au nevoie de vacularizare.
Cele expuse mai sus pledeaz n mod evident pentru implicarea TAM n angiogeneza
tumoral-indus prin formarea vaselor sangvine noi i remodelarea lor ulterioar ntr-o reea
vascular funcional. Fiind recrutate din sngele periferic, TAM migreaz n zonele de hipoxie a
tumorii, unde este nevoie acut de o reea vascular pentru supravieuirea celulelor tumorale,
fiind aici activate de ctre factorii de semnalizare locali. n urma activrii, la care sunt supuse,
macrofagele recrutate se difereniaz spre un fenotip polarizant ce sintetizeaz intens factori
proangiogeni. Acest lucru contribuie la formarea vaselor sangvine noi, fapt ce va determina
creterea local a tumorii i supravieuirea celulelor canceroase. Mai mult, sunt date despre
implicarea TAM i n procesul de limfogenez tumoral [13].
O perioad ndelungat de timp prezena macrofagelor n zona tumoral i peritumoral a
fost interpretat drept un rspuns adecvat al organismului gazd la tumoarea n cretere, aceast
prezen fiind considerat o ncercare a organismului de a inhiba procesul tumoral. Cu timpul,
ns, a devenit tot mai clar c TAM sunt nite actori activi n progresia tumorii i rspndirea
celulelor neoplazice. Studiile experimentale i preclinice au fost susinute de un numr mare de
studii clinice, care au gsit corelaii semnificative ntre densitatea macrofagal crescut i
prognosticul prost. TAM favorizeaz progresia tumorii prin multiple mecanisme: creterea
tumorii, invazie, imunosupresie i supravieuirea celulelor neoplazice, remodelarea stromal,
angiogenez, limfangiogenez, metastazare. Datorit acestei implicri multicomponente n
procesul de progresie TAM au devenit o int terapeutic atractiv. Au fost identificate 3 verigi
patogenetice de perspectiv, asupra crora s se influeneze medicamentos: 1) inhibiia recrutrii
lor n zona leziunii; 2) inhibiia efectului lor proangiogen i remodelrii stromale; 3) reversia
imunosupresiei cu restabilirea abilitilor sale citotoxice antitumorale.
Concluzii
1. Densitatea macrofagelor CD68 pozitive sporete pe msura progresiei neoplaziei de col
uterin, atingnd valori maxime n cu carcinoame scuamocelulare franc invazive.
2. Macrofagele CD68 pozitive sunt omniprezente n epiteliul neoplazic, unde au dimensiuni mai
mari i pot fi multinucleate.
1.
2.
3.
4.
5.
6.
7.
Bibliografie
Davidson B. et al. Macrophage infiltration and angiogenesis in cervical squamous cell
carcinoma clinicopathologic correlation. In: Acta Obstet Gynecol Scand. 1999, vol. 78, nr.
3, p. 240-244.
Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation
and wound healing. In: N Engl J Med. 1986, vol. 315, nr. 26, p. 1650-1659.
Elgert K.D., Alleva D.G., Mullins D.W. Tumor-induced immune dysfunction: the
macrophage connection. In: J Leukoc Biol. 1998, vol. 64, nr.3, p. 275-290.
Gonalves M.A., Donadi E.A. Immune cellular response to HPV: current concepts. In: Braz J
Infect Dis. 2004, vol. 8, nr. 1, p. 1-9.
Kobayashi A. et al. Evolving immunosuppressive microenvironment during human cervical
carcinogenesis. In: Mucosal Immunol. 2008, vol. 1, nr. 5, p. 412-420.
Leek R.D. et al. Necrosis correlates with high vascular density and focal macrophage
infiltration in invasive carcinoma of the breast. In: Br J Cancer. 1999, vol. 79, nr. 5-6, p. 991995.
Leek R.D., Harris A.L. Tumor-associated macrophages in breast cancer. In: J Mammary
Gland Biol Neoplasia. 2002, vol. 7, nr. 2, p. 177-189.
36
8. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments.
In: Cancer Res. 2006, vol. 66, nr. 2, p. 605-612.
9. Lin E.Y. et al. Vascular endothelial growth factor restores delayed tumor progression in
tumors depleted of macrophages. In: Mol Oncol. 2007, vol. 1, nr. 3, p. 288-302.
10. Martinez F.O. et al. Transcriptional profiling of the human monocyte-to macrophage
differentiation and polarization: new molecules and patterns of gene expression. In: J
Immunol. 2006, nr. 199, p. 73037311.
11. Mazuru V. Rolul pivotal al macrofagelor in progresia tumoral. In: Curierul medical. 2010,
nr. 4 (316), p. 5-61.
12. Nelson D., Ganss R. Tumor growth or regression: powered by inflammation. In: J Leukoc
Biol. 2006, vol. 80, nr. 4, p. 685-690.
13. Schoppmann S.F. et al. Tumor-associated macrophages express lymphatic endothelial
growth factors and are related to peritumoral lymphangiogenesis. In: Am J Pathol. 2002,
vol. 161, nr. 3, p. 947-956.
14. Tang Y. et al. Tumor-stroma interaction: positive feedback regulation of extracellular matrix
metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent
generation of soluble EMMPRIN. In: Mol Cancer Res. 2004, vol. 2, nr. 2, p. 73-80.
15. Tjiu J.W. et al. Tumor-associated macrophage-induced invasion and angiogenesis of human
basal cell carcinoma cells by cyclooxygenase-2 induction. In: J Invest Dermatol. 2009, vol.
129, nr. 4, p. 1016-1025.
16. Watkins S.K. et al. IL-12 rapidly alter the functional profiles of tumor-associated and tumorinfiltrating macrophages in vitro and in vivo. In: J Immunol. 2007, nr. 178, p. 13571362.
17. .. (
). In: . , -, 2001, 520.
Rezumat
Scopul lucrrii a fost studierea densitii microvasculare limfatice proliferante n leziunile
preneoplazice i neoplazice de cervix uterin. Material: metaplazie scuamoas (n=22) cazuri,
CIN I (n=14), CIN II (n=12), CIN III (n=6), carcinom microinvaziv (n=15), carcinom
invaziv (n=32). Metode: hematoxilin i eozin pentru diagnosticul histopatologic i
stadializarea leziunilor; dubl imunocolorare utiliznd tehnica LSAB+/HRP Double Stain. Au
fost utilizai pentru cercetare anti D2-40 i anti Ki-67. Numrarea vaselor limfatice s-a fcut prin
metoda hot spot modificat a lui Weidner. Rezultate: densitatea vaselor limfatice proliferante n
metaplazia scuamoas este egal cu 0,93; CIN I 1,4; CIN II 3,33; CIN III 4,56; carcinom
microinvaziv 3,01; carcinom invaziv 2,14. Limfaticele intratumorale au fost mici, colabate,
iar cele peritumorale medii sau mari, cu lumen evident. Au fost depistate 8 vase limfatice
proliferante cu emboli tumorali n lumen. Concluzii: leziunile preneoplazice i neoplazice
determin activ formarea limfaticelor de neoformaie, switch-ul limfangiogen ncepe n CIN I i
atinge apogeul n CIN III. Intensitatea limfangiogenezei tumorale n carcinoamele invazive nu
este mai mic dect n CIN. Metastazarea celulelor neoplazice are loc att prin limfaticele
preexistente, ct i prin cele de neoformaie.
Actualitatea
Carcinomul de cervix uterin reprezint una din cele mai frecvente afeciuni maligne umane.
Pe parcursul ultimelor decenii a fost demonstrat caracterul evident infecios a acestei maladii.
Este cunoscut nu numai agentul etiologic (papilomavirusul uman), dar i serotipurile cu potenial
cancerigen marcat, a fost introdus n practica medical vaccinarea mpotriva acestui agent.
Aceste evenimente au avut drept efect micorarea dramatic a incidenei neoplaziei de cervix
uterin. Exist, ns, regiuni cum ar fi Africa ecuatorial (Uganda, Rwanda), America Central
(Mexic, Honduras, Costa Rica), America de Sud (Columbia, Bolivia, Brazilia, Peru), rile
Europei de Sud-est, n care morbiditatea i mortalitatea prin carcinomul de col uterin ocup
poziii de top n patologia oncologic[1]. Astfel, este absolut firesc interesul fa de aceast
afeciune n rndul cercettorilor de specialitate.
Pe parcursul ultimelor decenii a fost demonstrat faptul, c pentru progresia tumoral au
importan nu numai evenimentele ce se petrec n celulele tumorale (indiferent de tumor), ci i
care au loc n stroma intratumoral i peritumoral. Este bine cunoscut faptul c orice tumoare, la
etapa iniial de dezvoltare, i satisface necesitile nutritive, plastice i respiratorii din contul
reelei vasculare preexistente. Pe parcursul creterii, intervine un moment critic, cnd aceste
necesiti nu mai pot fi acoperite de ctre reeaua vascular preexistent. n acest moment
tumoarea i celulele stromei (celulele rezidente, celulele inflamatorii recrutate din sngele
periferic) ncep o colaborare coordonat n vederea formrii unei reele vasculare noi[2] prin
remodelarea stromal i sinteza factorilor de cretere (mitogeni pentru endoteliul att vascular,
ct i limfatic). Angiogeneza tumoral a fost studiat cu lux de amnunte. Se cunosc bine
circumstanele, mecanismele moleculare i consecinele acestui fenomen. n schimb, fenomenul
de formare al vaselor limfatice, sub aciunea tumorii, este mult mai puin studiat.
Limfangiogeneza tumoral este un fenomen biopatologic ce decurge paralel sau secundar
angiogenezei [3]. Este bine cunoscut faptul c tumorile solide metastazeaz prin cteva ci: per
continuam, prin vasele sangvine i prin cele limfatice. Rspndirea celulelor neoplazice pe cale
limfatic este calea primar de metastazare pentru un ir de neoplazii cum ar fi: carcinomul
cervical, ovarian, mamar, gastric, pulmonar[4]. n rezultatul acestei metastazri sunt implicai n
proces ganglionii limfatici regionali, aspect care coreleaz cu nrutirea prognosticului de
supravieuire la pacienii respectivi[5]. Descoperirea marcherilor specifici pentru endoteliul
limfatic a constituit un salt important n studiul limfangiogenezei fiziologice i tumorale. Una din
ntrebrile la care nu exist un rspuns echivoc pn n prezent este originea vaselor limfatice
prin intermediul crora are loc metastazarea celulelor neoplazice: prin vasele limfatice
preexistente sau prin reeaua vascular limfatic format de tumor[6].
38
Scopul
Reieind din cele expuse, scopul lucrrii, a fost studiul limfangiogenezei n leziunile
colului uterin prin depistarea proliferrii endoteliocitelor limfatice cu ajutorul anticorpului
monoclonal anti Ki-67.
Material i metode
Au fost supuse studiului specimenele obinute prin biopsii intite i conizaie de la
pacientele cu leziuni macroscopic decelabile. Materialul biologic a fost fixat n soluie de formol
tamponat. Dup splarea n ap de robinet, dehidratarea n soluii descrescnde de alcool i
clarefierea n soluie de xilen, specimenele au fost incluzionate n parafin. ntreaga prelucrare
preliminar a materialului a fost efectuat n conformitate cu prevederile tehnicii histologice
convenionale. Seciunile, cu grosimea de 3mkm, au fost fcute la microtomul de tip sliding
ERMA Japan. Diagnosticul histopatologic i gradarea leziunilor au fost efectuate prin colorarea
cu hematoxilin i eozin. Au fost identificate urmtoarele tipuri de leziuni: metaplazie
scuamoas (n=22), CIN I (n=14), CIN II (n=12), CIN III (n=6), carcinom microinvaziv (n=15) i
carcinom invaziv (n=32). Am efectuat dubl imunocolorare a seciunilor, utiliznd 2 anticorpi
monoclonali: anti Ki-67 clona MIB1 Dako Cytomation (Carpinteria, CA, USA) i anti D2-40
clona D2-40 DakoCytomation (Danemarca). Anti Ki-67 a fost utilizat pentru evidenierea
endoteliocitelor limfatice proliferante, iar anti D2-40 pentru a pune n eviden vasele limfatice
i, astfel, de a diferenia anume endoteliul limfaticelor pozitiv la anti Ki-67 de alte elemente
celulare ale tumorii aflate n proliferare (Ex endoteliul vaselor sangvine). Tehnica
imunohistochimic utilizat a fost LSAB+/HRP Double Stain. Demascarea antigenic s-a fcut n
soluie Target Retrieval pH6, la temperatura 97oC, timp de 20 minute. Primul anticorp aplicat a
fost anti D2-40, cu timpul de incubare 30 minute, apoi s-a aplicat sistemul avidin-biotin HRP, iar
vizalizarea s-a fcut cu 3,3'-diaminobenzidin (DAB) n calitate de cromogen. Al doilea anticorp
aplicat a fost anti Ki-67 cu perioada de incubare 30 minute. Dup aplicarea sistemului avidinbiotin HRP, vizualizarea s-a fcut cu cromogenul amino-etilcarbazol (AEC). Pentru
contracolorarea nucleilor a fost utilizat hematoxilina Lille modificat. Specimenele histologice
colorate imunohistochimic au fost montate n mediu apos. Procedura de imunocolorare a fost
efectuat cu ajutorul DakoCytomation Autostainer. Examinarea lamelor histologice s-a fcut la
microscopul Nikon Eclipse E600.
Cuantificarea densitii microvasculare limfatice (LMVD) s-a efectuat n conformitate cu
metoda modificat a cmpurilor fierbini (hot spot) a lui Weidner[7]. Ea const n examinarea, la
amplificarea X200, a trei cmpuri de strom localizate n imediata vecintate a neoplaziei sau a
epiteliului normal, n care expresia anticorpului mai puternic exprim. Suma primit n rezultatul
identificrii structurilor int se mparte la 3, iar media aritmetic obinut este rezultatul final al
examinrii unui caz. Au fost numrate doar acele vase limfatice, pozitive la D2-40, la care s-a
depistat cel puin o celul endotelial Ki-67 pozitiv.
Rezultate
LMVD Ki-67 pozitive n metaplaziile scuamoase. n 8 cazuri nu a fost depistat nici un vas
limfatic (VL) cu endoteliocite proliferante. Densitatea maximal a fost de 2,8 VL, valoarea
medie fiind de 0,93 VL.
LMVD Ki-67 pozitive n leziunile preneoplazice. S-a constatat o cretere stabil a
numrului de VL proliferante o dat cu progresia gradului de leziune intraepitelial. n CIN I
numrul VL cu endoteliocite proliferante a variat ntre 0 (n 2 cazuri) i 2,4. Media a fost de 1,4.
n CIN II rezultatele au variat ntre 0 (ntr-un singur caz) i 3,8. Media a constituit 3,33 VL. n
CIN III, n toate cazurile au fost detectate VL Ki-67 pozitive. Densitatea lor a variat ntre 4 i 5,2
cu medie de 4,56. E de menionat faptul c n leziunile intraepiteliale de grad nalt (CIN II i mai
ales CIN III) vasele limfatice se depistau deja nu numai n stroma profund, dar i n imediata
vecintate cu membrana bazal a epiteliului exocervical. Majoritatea VL Ki-67 pozitive aveau un
lumen bine definit (erau perfuzabile).
39
rmne totui un indiciu indirect, de constatare, al neoformrii acestor vase. Din aceast cauz
am decis s studiem densitatea vaselor limfatice proliferante, utiliznd markerul proliferrii
nucleare Ki-67.
Ki-67 este o protein nuclear, care se exprim preferenial pe parcursul fazelor active ale
ciclului celular (G1, S, G2 i M), dar nu se expreseaz n celulele aflate n G0[15]. n interfaz,
antigenul este depistat exclusiv n nucleu, n timp ce pe parcursul mitozei markerul se localizeaz
pe suprafaa cromozomilor. n celulele ce intr n faza non-proliferativ, antigenul este rapid
supus degradrii[16].
Rezultatele acestei cercetri indic faptul, c pe parcursul evoluiei neoplaziei de col col
uterin are loc formarea de VL tumoral-derivate. Rata limfaticelor proliferante are o dinamic
comparabil cu densitatea general de vase limfatice, curbele lor de cretere i descretere fiind
identic.
Marea majoritate a studiilor axate pe morfologia VL din zonele intratumoral i
peritumoral pledeaz pentru ideea c limfaticele din plaja tumorii nu sunt funcionale[17; 18],
rolul n rspndirea celulelor neoplazice revenind limfaticelor de la periferia tumorii[19]. Totui
exist date, foarte puine, despre unele tumori n care limfaticele intratumorale sunt
funcionale[20]. Aceste rezultate stau la baza conceptului conform cruia anume limfaticele
peritumorale asigur rspndirea celulelor neoplazice pe cale limfovascular. Rezultatele noastre
confirm aceste date. n carcinoamele invazive, limfaticele intratumorale, att VL D2-40+, ct i
Ki-67+ sunt mici i colabate, lipsite de lumen. Limfaticele din aria peritumoral, ns, sunt medii
sau mari cu un lumen evident. Mai mult, au fost depistate VL cu emboli tumorali doar n ariile
peritumorale. Prezena embolilor tumorali i n limfaticele activate indic faptul c, n
carcinoamele cervicale invazive, sunt implicate n metastazarea limfovascular att limfaticele
preexistente, ct i cele de neoformaie.
Concluzii
Limfangiogeneza tumoral este unul din evenimentele cheie care se produce n cadrul
progresiei neoplaziei de col uterin. n baza rezultatelor despre densitatea microvascular
limfatic general, dar mai ales cea proliferant, corelat la stadiul de progresie al leziunii
cervicale am constatat c debutul formrii de vase limfatice, condiionat de leziune, ncepe la
nivelul de CIN I i crete progresiv, atingnd apogeul su la nivelul de CIN III. O dat cu
apariia invaziei densitatea limfaticelor scade, ajungnd n carcinoamele frank invazive s fie la
un nivel comparabil cu nivelul LMVD din CIN II. Acest aspect denot faptul c pe parcursul
evoluiei neoplaziei cervicale are loc formarea unei reele vasculare limfatice de neoformaie. n
opinia noastr, datorit faptului c raportul LMVD general/LMVD proliferant rmne acelai, n
carcinoamele invazive are loc o limfangiogenez tumoral tot att de intens ca i n leziunile
preneoplazice, chiar dac densitatea VL este simitor n descretere. Prezena embolilor tumorali
i n interiorul VL proliferante ne face s concluzionm c metastazarea limfovascular n
carcinoamele cervicale invazive are loc att prin limfaticele preexistente, ct i prin cele aprute
n rezultatul limfangiogenezei tumorale.
Bibliografie
1. Ferlay J, Parkin DM, Pisani P. GLOBOCAN 1: cancer incidence and mortality
worldwide. IARC CancerBase no 3. Lyon: IARCPress; 1998.
2. Oliver G. Lymphatic vasculature development. Nature Rev Immunol. 4, 35-45 (2004).
3. Alitalo K, Tammela T, Petrova V. Lymphangiogenesis in development and human
disease. Nature 438, 946-953 (2005).
4. Fidler IJ. The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited.
Nat. Rev. Cancer, 3, 453-458 (2003).
5. Alitalo K, Mohla S, Ruoslahti E. Lymphangiogenesis and Cancer: Meeting Report.
Cancer Research 64, 9225-9229 (2004).
41
6. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and
cancer metastasis. Nat. Rev. Cancer, 2, 573-583 (2002).
7. Weidner N. Current pathologic methods for measuring intratumoral microvessel density
with breast carcinoma and other solid tumors. Breast Cancer Res Treat, 36, 169-180
(1995).
8. Skobe M, Hawighorst T, Jackson D et al. Induction of tumor lymphangiogenesis by
VEGF-C promotes breast cancer metastasis. Nat. Med., 7, 192-198 (2001).
9. Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R. Lymphangiogenesis
in prostate carcinoma assessed with novel lymphatic marker, lymphatic vessel endothelial
hyaluronan receptor (LYVE-1). J. Urol, 172, 103-107 (2004).
10. He Y, Rajante I, Pajusola K et al., Vascular endothelial cell growth factor receptor 3
mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread
via lymphatic vessels. Cancer Res, 65, 6901-6909 (2005).
11. Yuanming L, Feng G, Lei T, Ying W. Quantitative analyses of lymphangiogenic markers
in human gastroenteric tumor. Archives of Medical Research, 38, 106-112 (2006).
12. Saptefrati L, Cimpean AM, Ciornii A, Ceausu R, Esanu N, Raica M. Identification of
lymphatic vessels and prognostic value of lymphatic microvessel density in lesions of the
uterine cervix. Romanian Journal of Morphology and Embryology, 50(4), 589-594
(2009).
13. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G., Peritumoral lymphatic vessel density and
vascular endothelial growth factor C expression in early stage squamous cell carcinoma
of the uterine cervix. Clin Cancer Res, 11(23), 8367-8371 (2005).
14. Roma AA, Magi-Galluzzi C, Kral MA, Jin TT, Klein EA, Zhou M., Peritumoral
lymphatic invasion is associated with regional lymph node metastasis in prostate
adenocarcinoma., Mod Pathol, 19(3), 392-398 (2006).
15. Gerdes J, Lemke H, Baisich H, Wacker HH, Schwab U, Stein H., Cell cycle analysis of a
cell proliferation-associated human nuclear antigen defined by the monoclonal antibody
Ki-67. J Immunol, 133, 1710-1715 (1984).
16. Scholzen T, Gerdes J., The Ki-67 protein: from the unknown to known. J Cell Physiol
182, 311-322 (2000).
17. Padera PT, Kadambi A, di Tomaso E., Lymphatic metastasis in the absence of functional
intratumor lymphatics. Science, 296, 1883-1886 (2002).
18. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK., Absence of functional
lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res.,
60, 4324-4327 (2000).
19. Schopman SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K,
Alitalo K, Kerjaschki D., Tumor-associated macrophages express lymphatic endothelial
growth factors and are related to peritumoral lymphangiogenesis, Am. J. Pathol, 16(3),
947-956 (2002).
20. Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D, Kloppel G., Expression of
lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic
endocrine tumors. Am. J. Pathol., 165, 1187-1197 (2004).
42
severe. Deoarece cercettorii din diverse ri i domenii utilizau diferite metode de evideniere,
izolare sau cultivare, s-a fondat Comitetul celulelor MSC a Societii Internaionale pentru
terapia celular. Acesta a propus criterii minime pentru definirea MSC umane: primul criteriu
s se menin aderent pe suporturile de cultivare; al doilea s exprime pe suprafa antigenii
CD105, CD73 i CD90 i s nu exprime CD45, CD34, CD14 ori CD11b, CD79a ori CD19,
HLA-DR; al treilea rnd necesit s aib capacitatea de a se diferenia n vitro n osteoblaste,
chondroblaste i adipocite (38, 39).
Celulele MSC din complesul ombilico placentar sunt mai avantajate dect cele din
mduva osoas deoarece:
Sunt uor de prelevat, conservat (congelat) i utilizat (clinic, manipulaii genetice)
Donatorul nu este omul ci componenta extraembrionar
Au compatibilitate imun ridicat, HLA antigen este absent sau slab evideniat
Se pot stoca pentru a forma bnci de celule stem proprii
Foarte intens pn n present s-a studiat sngele din cordonul umbilical, cu toate c unii
cercettori susin c majoritatea MSC se afl n esuturile complesul ombilico placentar (54).
esutul mucos conjunctiv al cordonului ombilical (jeleul Warton) este cel mai tnr esut
conjunctivcare poate induce formarea, celulelor esutului nervos (neuroni i celule gliale)(54).
Celulele mesenchimale depistate n amnion la fel au un diapazon foarte larg de difereniere
(multipotente) i au fost catalogate ca viitorul medicinii de ctre biserica catolic care
condamn cercetarea utiliznd embrionii.
Toate aciunile legate de celulele stem sunt reglate de legi i acreditate la nivel naional,
precum i internaional.
Mecanismele de aciune ale celulelor mezenchimale stem nu sunt pe deplin elucidate.
Proprietatea MSC de a fi lipsite de HLA antigeni le transform n celule invizibile pentru
celulele sistemului imunitar gazd, n cazul unui transplant alogen. Unele aciuni ale celulelor
stem ar fi c ele induc diferenierea esutului specific n mediul n care a fost transplantat MSC,
reparar micromediului tisular, posed efecte para- i juxtacrine ale factorilor de cretere i a
citochinelor produse de aceste celule sau de reorganizez matricea extracelular.
Utilitatea celulelor stem mesenchimale a fost demonstrat n:
Patologia cardiovascular. Injectarea celulelor stem n zona ischemic cardiac a dus
la diferenierea cardiomiocitelor, celulelor endoteliale i miocitelor. Ca efect n inima cu infarct
miocardic s-a remodelat miocardul i s-au reparat vasele prin neoangiogenez. MSC cu astfel de
aciuni, avea marcherul CD105 ce se preleva din sngele cordonului ombilical, esut adipos i
din mduva osoas (40, 41). Celulele stem i cele progenitoare cardiace rezidente sunt foarte
asemntoare att fenotipic ct i genotipic.
Patologia osoas i cartilaginoas. Sunt aplicate cu succes n tratamentul osteogenezei
imperfecte caracterizat cu fracturi multiple, cauzate de sinteza defect a colagenului tip I (1,
42). MSC fiind inoculate n zonele de reparaie osoas sau cartilaginoas induc activitatea
pericitelor, ca progenitori celulari care au posibiliti modulatorii asupra matricii exracelulare,
potenial de migraie de proliferare, de re-diferenciere. O surs de celule mezenchimale stem
poate fi MSC din in situ microfracturi, esutul de granulaie, esutul adipos adiacent.
Patologia renal. Se ncearc s fie utilizate MSC n boli cu aspect inflamator, imunitar
i autoimunitar. Sunt rezultate mbucurtoare n tratarea patologiei glomerulare i tubulare
renale. (43, 44). Studiile recente pun n eviden sugestia c celulele interstiiale pot fi
considerate ca un depou de celule progenitoare stem mezenchimale extratubulare. Astfel n
patologia renal restabilirea se petrece prin intermediul celulelor mezenchimale stem locale sau
prin inocularea MSC allogene.
Patologia pielii. S-a observat un potenial mare de reparare a esutului cutanat pe
modele animale i la oameni n tratamentului plgilor de origini diverse (45). n timpul
cicatrizrii cutanate se confrunt dou procese de reparaie i antiinflamator.
Ambele sunt
mediate de substanele produse de celulele progenitoare locale, celule stem de provinin a.
Recent sau evideniat ca celule stem mezenchimale - celulele stem ale foliculilor pieloi ai
44
adulilor. Celulele stem ale folicolului pielos sunt o ni de celule progenitoare care duc la
regenerarea prului, glandelor sudoripare, sebacee i a epidermisului.
Patologia nervoas. O mulime de ncercri se fac n terapia patologiilor sistemului
nervos central i periferic. ncepnd cu bolile neurodegenerative periferice i cele din CNS
(boala demielinizant, Huntington, Parkinson), pn la patologii vasculare, ischemice, traume ale
componentelor SNC i SNP. Se observ careva efecte pozitive, benefice n tratarea parezei
infantile (46-48). MSC induc formarea factorului neuronal de cretere edndogen, descrete
apoptoza, reduce nivelul radicalilor liberi, mbuntete conexiunea sinaptic a neuronilor
afectai. Aceste aciuni MSC le promoveaz prin activiti paracrine producnd factori trofici,
care sunt insuficieni n cazul leziunilor nervoase, aceti factori trofici neuronali i gliali induc
regenerarea i supravieuirea neuronilor locali n cazurile de ictus cerebral i maladiile
neurodegenerative.
Patologia pulmonar. n sindromul de disstres respirator acut se observ o reducere
dramatic a esutului pulmonar, ca rezultat al procesului inflamator i de fibrozare. Prin tehnici
de transplant cu celule stem se ncearc stabilizarea esutului pulmonar i chiar remodelarea
acestuia (49,50). Celulele stem mezenchimale promoveaz repararea vascular i regenerarea
epitelial, de asemenea intervine la etapa de modulare a sistemului imunitar.
Diabetul zaharat. Studiile clinice demonstreaz o reducere considerabil a nivelului
glucozei sangvine n diabetul zaharat juvenil tip I, dup utilizarea SMC. Din celule
mezenchimale stem din cordonul ombilical gelul Wharton se formeaz celule productoare de
insulin n insulele formate de novo (51, 52). Mediatorii imunoreglatori sintetizai de ctre SMC
inhib aciunea pro-inflamatorie a citochinelor prezente n inlamaiile post transplant.
Boli autoimune. Multitudinea de nozologii autoimune din diferite sisteme ale
organismului (scleroz multipl, artrit reumatoid, lupus eritematos sistemic) sunt ca rezultat al
activitii imperfecte a sistemului imunitar. Studiile recente arat aciunea imunosupresoare a
SMC n astfel de patologii (53). De asemenea sunt atestate rezultate pozitive n tratamentul
maladiilor autoimune n combinaie cu cele tradiionale, n special cu tehnicile manipulatorii de
selecie a celulelor limfocitare T.
Pentru aceasta n perspectiva noilor tendine tiinifice i aplicative este necesar de a
pune n eviden majoritatea subtilitilor structurare ale complexului ombilical placentar prin
metode morfologice, histochimice i aprecierea posibilitii utilizrii lor n medicina practic.
Dezvoltnd noi metode terapeutice sunt posibile de rezolvat multe probleme de asisten
medical. Transplantarea CMS ntr-un tratament complex va da un beneficiu att pacienilor ct
i economiei. n timp, cu adncirea cunotinelor n domeniul grefrilor celulare cu MSC vor
avansa foarte mult strategiile de tratament ale multor boli n prezent incurabile.
Bibliogafie
1. Viorel Nacu. Optimizarea regenerrii osoase post traumatide dereglate. Chisinau, 2010 p.6371
2. Ababii I., Nacu V., Friptu V., Ciobanu P., Revencu T., Ghid practic de prelevare a sngelui
ombelico placentar. Chiinu 2008. 36 p
3. Ababii I., Ciobanu P., Eanu N., Topor B., Nacu V., Actualiti i perspective n transplantarea
celular, Curierul medical, v3 (285) 2005, p 42-47
4 Nacu V. Metode biologice stimulatoare a procesului reparator osos, Curierul medical, v3 (309)
2008, p 37-45
5. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic
tissues. Science.1997;276:7174. [PubMed]
6. Conget PA, JJ Minguell. Phenotypical and functional properties of human bone marrow
mesenchymal progenitor cells. J Cell Physiol. 1999;181:6773. [PubMed]
7. Alhadlaq A, Mao JJ. Tissue-engineered neo-genesis of human-shaped mandibular condyle
from rat mesenchymal stem cells. J Dent Res. 2003;82:951956. [PubMed]
45
8. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca J, Moorman M,
Simonetti D, Craig S, Marshak DR. Multilineage potential of mesenchymal
cells. Science. 1999;284:143147.[PubMed]
9 Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal
stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18:14171426. [PubMed]
10. Makino S, Fukuda K, Miyoshi S, Konishi F, Ko-dama H, Pan J, Sano M, Takahashi T, Hori
S, Abe H, Hata J, Umezawa A, Ogawa S. Cardio-myocytes can be generated from marrow
stromal cells in vitro. J Clin Invest. 1999;103:697705. [PMC free article] [PubMed]
11. Planat-Bnard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, Penicaud L,
Casteilla L. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ
Res.2004;94:223229. [PubMed]
12. Oswald J, Boxberger S, Jrgensen B, Feldmann S, Ehninger G, Bornhuser M, Werner C.
Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem
Cells.2004;22:377384. [PubMed]
13. Chagraoui J, Lepage-Noll A, Anjo A, Uzan G, Charbord P. Fetal liver stroma consists of
cells in epithelial-to-mesenchymal transition. Blood. 2003;101:29732982. [PubMed]
14. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal
cells differentiate into neurons. J Neurosci Res. 2000;61:364370. [PubMed]
15. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, Peister A, Wang MY, Prockop
DJ. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by
human adult stem cells for bone marrow stroma. Proc Natl Acad Sci USA. 2003;100:2397
2402.[PMC free article] [PubMed]
16. Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, Du Y, Li L. Reconstruction of chemically
burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem
Cells.2006;24:315321. [PubMed]
17. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M
Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA
Largaespada, CM Verfaillie. Pluripotency of mesenchymal stem cells derived from adult
marrow. Nature. 2002;418:4149. [PubMed]
18. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, et al.
Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in
vitro colony assay method. Exp Hematol. 1974;2:8392. [PubMed]
19. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from
human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211
28. [PubMed]
20. Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP, Caplan AI. In vitro
differentiation of bone and hypertrophic cartilage from periostealderived cells. Exp Cell
Res.1991;195:492503. [PubMed]
21. Nathanson MA. Bone matrix-directed chondro-genesis of muscle in vitro. Clin Orthop Relat
Res.1985:14258. [PubMed]
22. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic
potential of esenchymal stromal stem cells from human vertebral bone marrow. J Bone
Miner Res.1999;14:111522. [PubMed]
23. In't Anker PS, Scherjon SA, Kleijburgvan der Keur C, de Groot-Swings GM, Claas FH,
Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human
placenta.Stem Cells. 2004;22:133845. [PubMed]
24. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord
blood.Br J Haematol. 2000;109:23542. [PubMed]
25. Panepucci RA, Siufi JL, Silva WA, Jr, Proto-Siquiera R, Neder L, Orellana M, et al.
Comparison of gene expression of umbilical cord vein and bone marrowderived
mesenchymal stem cells. Stem Cells. 2004;22:126378. [PubMed]
46
26. Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, et al. Stem cell properties of
human
dental
pulp
stem
cells. J
Dent
Res. 2002;81:531535.
doi:
10.1177/154405910208100806. [PubMed][Cross Ref]
27. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al.
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41
49. doi: 10.1038/nature00870. [PubMed] [Cross Ref]
28. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent
mesenchymal stem cells from umbilical cord blood. Blood. 2004;103:16691675. doi:
10.1182/blood-2003-05-1670. [PubMed] [Cross Ref]
29. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cergueira A, Carvalho MD, et al. Multipotent
stem cells from umbilical cord: cord is richer than blood! Stem Cells. 2008;26:146150. doi:
10.1634/stemcells.2007-0381. [PubMed] [Cross Ref]
30. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cergueira A, Carvalho MD, et al.
Mesenchymal stem cells from umbilical cord: do not discard the cord! Neuromuscul
Disord. 2008;18:1718. doi: 10.1016/j.nmd.2007.11.003. [PubMed] [Cross Ref]
31. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from
human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211228.
doi: 10.1089/107632701300062859. [PubMed] [Cross Ref]
32. Covas DT, Panepucci RA, Fontes AM, Silva WA, Orellana MD, Freitas MC, et al.
Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional
properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp
Hematol. 2008;36:642654. doi: 33.1016/j.exphem.2007.12.015. [PubMed] [Cross Ref]
34. Crisan M, Yap S, Casteilla L, Chen C-W, Corselli M, Park TS, et al. A perivascular origin
for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301313. doi:
10.1016/j.stem.2008.07.003. [PubMed] [Cross Ref]
35. Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal
stem
cells.Stem
Cells. 2008;26:22872299.
doi:
10.1634
/stemcells
.20071122. [PubMed] [Cross Ref]
36. Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all
post-natal
organs
and
tissues. J
Cell
Sci. 2006;119:22042213.
doi:
10.1242/jcs.02932. [PubMed][Cross Ref]
37. da Silva Meirelles, L., Sand, T. T., Harman, R. J., Lennon, D. P., & Caplan, A. I. (2008).
MSC Frequency Correlates with Blood Vessel Density in Equine Adipose Tissue. Tissue Eng
Part A.
38. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R,
Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal
stromal cells. The International Society for Cellular Therapy position
statement. Cytotherapy. 2006;8:3157. [PubMed]
39. Senseb L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells
for clinical application. Vox Sang. 2010;98:93107. [PubMed]
40. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted
myocardium.Nature. 2001;410:7015. [PubMed]
41. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and
support myocardial regeneration. Cell. 2003;114:76376.12. [PubMed]
42. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal
stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler
syndrome (MPS-IH)Bone Marrow Transpl. 2002;30:21522.
43. Qian H, Yang H, Xu W, Yan Y, Chen Q, Zhu W, Cao H, Yin Q, Zhou H, Mao F, Chen Y.
Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation
into renal tubular epithelial-like cells. Int J Mol Med. 2008;22:325332. [PubMed]
44. Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico
N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G. Human bone marrow mesenchymal stem
47
cells accelerate recovery of acute renal injury and prolong survival in mice. Stem
Cells. 2008;26:20752082.[PubMed]
45. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P.
Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin
spray accelerate healing in murine and human cutaneous wounds. Tissue
Eng. 2007;13:12991312.[PubMed]
46. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS,
Velagaleti G, Troyer D. Human umbilical cord matrix stem cells: preliminary
characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem
Cells. 2006;24:781792.[PubMed]
47. Sanberg PR, Willing AE, Garbuzova-Davis S, Saporta S, Liu G, Sanberg CD, Bickford PC,
Klasko SK, El-Badri NS. Umbilical cord blood-derived stem cells and brain repair. Ann N Y
Acad Sci. 2005;1049:6783. [PubMed]
48. Chung DJ, Choi CB, Lee SH, Kang EH, Lee JH, Hwang SH, Han H, Lee JH, Choe BY, Lee
SY, Kim HY. Intraarterially delivered human umbilical cord blood-derived mesenchymal
stem cells in canine cerebral ischemia. J Neurosci Res. 2009;87:35543567. [PubMed]
49. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, Kang S, Jin HJ, Yang YS, Park
WS. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxiainduced lung injury in neonatal rats. Cell Transplant. 2009;18(8):86986. [PubMed]
50. Ortiz LA, Gambelli F, McBride C, Gaupp D, Bad-doo M, Kaminski N, Phinney DG.
Mesenchymal stem cell engraftment in lung is enchanced in response to bleomycin exposure
and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003;100:84078411. [PMC
free article][PubMed]
51. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous
umbilical
cord
blood
transfusion
for
type
1
diabetes. Experimental
Hematology. 2008;36:710715.[PMC free article] [PubMed]
52. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J,
Sanberg PR. Intravenous versus intrastriatal cord blood administration in a rodent model of
stroke.Journal of Neuroscience Research. 2003;73:296307. [PubMed]
53. Chang JW, Hung SP, Wu HH, Wu WM, Yang AH, Tsai HL, Yang LY, Lee OK. Therapeutic
Effects of Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation in
Experimental Lupus Nephritis. Cell Transplant. 2010 [Epub ahead of print]
54. Hwai-Shi Wang, Shih-Chieh Hung, Shu-Tine Peng, Chun-Chieh Huang,Hung-Mu Wei, YiJhih Guo, Yu-Show Fu, Mei-Chun Lai, Chin-Chang Chen, Mesenchymal Stem Cells in the
Whartonis
Jelly
of
the
Human
Umbilical
Cord,
TEMCELLS2004;22:1330n1337www.StemCells.com
Rezumat
Anumite aspecte a mecanismului regenerrii hepatice (Review)
ntr-un ficat adult sntos numai o hepatocit din 20.000 (0.005%) exist n ciclul celular
in stare de deviziune. Restul sunt pasive n stare G0. Acest articol se axeaz pe evenimentele
anticipate care au loc n ficat, dup deteriorarea parial (chimic sau prin hepatectomie).
nelegerea cilor de semnalizare, prin care hepatocitele permit meninerea capacitilor
homeostatice si funciilor importante pentru restituirea complet a esutului deteriorat sau
pierdut, propune noi strategii pentru tratarea afeciunilor hepatice.
The liver plays a central role in metabolic homeostasis, as it is responsible for the
metabolism, synthesis, storage and redistribution of nutrients, carbohydrates, fats and vitamins.
The liver produces large numbers of serum proteins including albumin and acute-phase proteins,
enzymes and cofactors. Importantly, it is the main detoxifying organ of the body, which removes
wastes and xenobiotics by metabolic conversion and biliary excretion [6, 12, 16, 19].
Liver regeneration has been recognized by scientists for many years and was even
described by the ancient Greeks, who mentioned liver regeneration in the myth of Prometheus.
Having stolen the secret of fire from the gods of Olympus, Prometheus drew down on himself the
anger of Zeus, the ruler of gods and men. Zeus punished Prometheus by chaining him to Mount
Caucasus where he was tormented by an eagle. The eagle preyed on Prometheus liver, which
was renewed as fast as it was devoured (Bulfinchs Mythology) [16].
It is known adult hepatocytes are long lived and normally do not undergo cell division,
they maintain the ability to proliferate in response to toxic injury and infection. After a partial
hepatectomy (removal of a section of the liver), liver cells reenter the cell cycle and replicate
until the liver recovers its lost mass, within a precision of 10% [9, 12, 16, 19]. There is know a
very phenomenal capacity that in liver regeneration does not require the recruitment of liver stem
cells or progenitor cells, but involves replication of the mature functioning liver cells. However,
it was proved the existence of facultative stem cells in the liver which are undifferentiated cells
as typical stem cell and found in the system of bile canals (Hering canals). Its nearest precursors,
oval cells can give rise to several cell lines, including hepatocytes and biliary epithelial cells [9,
16]. The regenerative process is compensatory because the size of the resultant liver is
determined by the demands of the organism, and, once the original mass of the liver has been
reestablished, proliferation stops [1, 11]. The reasons for initiating the regeneration stage, up to
now finally be resolved. One theory suggests that hemodynamic overload, which is subjected to
the remainder of the liver after its resection, activates inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2, which leads to increased production of nitric oxide (NO) and prostaglandins
[9, 13]. It stresses the importance of preserving portal blood flow and the consistency is
maintained by the hepatic arterial buffer response [17].
Although numerous studies have investigated the molecular mechanisms of liver
regeneration, including the roles of cytokines, growth factors, matrix remodeling, and metabolic
signals [3, 7, 9, 15], any basic questions remain. What are the signals that trigger the early events
in the regenerative process? What role plays stem cells in liver regeneration?
Investigators have begun to answer these questions by using molecular and genetic
approaches to identify the important regulatory pathways that control the regenerative process.
There are different models of study the process of liver regeneration. The most important are
model using chemical administration of hepatotoxic chemicals (e.g. carbon tetrachloride) and
surgical model (technique of partial hepatectomy) [6, 9, 19]. Of course the initial response
reactions are different depend of the nature of damage. For example, during the injury to the
tissue results in disruption of capillary vascular networks and extravasation of blood,
accompanied by local release of coagulation factors, platelets, growth factors, etc. [7, 15]. There
is considerable literature suggesting that the early hemodynamic changes after partial
hepatectomy are important of all aspects of liver regeneration. The importance of the
hemodynamic events and the change of relative proportion of portal to arterial blood are the least
49
studied and least understood. The one of theories suggests that hemodynamic overload after the
liver resection activates inducible nitric oxide synthase (iNOS) and cyclooxygenase-2, which
leads to increased production of nitric oxide (NO) and prostaglandins [2, 7, 9, 13]. NO and
prostaglandins sensitize macrophages to the liver secondary inductors of inflammation,
especially to the endotoxin of gram-negative intestinal microflora, whose level in serum after
liver resection increases. It is related to bacterial translocation from the gut due to a violation of
local immunity, changes in the composition of flora and increase its permeability, and with a
decrease in the absolute number of Kupffer cells and inhibition of their function [6, 7, 13].
Sensitized macrophages produce tumor necrosis factor (TNF-), which is a multifunctional
cytokine, transmitting signals through two types of receptors: TNFR-1 (p55) and TNFR-2 (p75)
[5, 15]. It acts as a mediator of acute-phase response in the liver and has a cytotoxic effect by the
amplified DNA synthesis (phase S), reaching a maximum between 24 and 48 hours after
resection. The peak of DNA synthesis of biliary epithelium cells has observed after 36-48 h,
Kupffer and stellate cells - after 48 h and, finally, the endothelial cells of sinusoids - after 96 h of
surgery [11, 14, 16]. The conversion through the phases of the cell cycle is modulated by the
interaction between cyclins, cyclin-dependent kinases and its inhibitors. After 7-10 days after the
hepatectomy the liver regeneration stops [14].
In a healthy adult liver, only ~1 hepatocyte in 20,000 (0.005%) is in the cell cycle [23].
The rest are quiescent, in the G0 state. After partial hepatectomy, hepatocytes reenter the cell
cycle by going from the G0 state to the G1 phase. Cells in the early G1 phase progress, driven by
growth factors, through the G1/S restriction point, after which cells are committed to progress to
mitosis, even in the absence of the G1 growth factors. However, cells in early G1 phase that have
not reached the restriction point can return to quiescence in the absence of growth factors [11,
15, 16]. Fausto and Riehle have considered three subpopulations of hepatocytes: quiescent cells
(Q), primed cells (P), and replicating cells (R) [2]. In the priming phase of liver regeneration,
multiple immediate-early genes such as c-fos and c-jun are induced [11].
Early events occurring in liver after partial hepatectomy
The partial hepatectomy induces rapid induction of more than 100 genes not expressed in
normal liver [11, 15, 19]. These genes relate directly or indirectly to preparative events for the
entry of hepatocytes into the cell cycle. The functions served are several and many of these genes
(e.g., IGFBP1) appear to play an essential role. One of the earliest observed biochemical changes
is increase in activity of urokinase plasminogen activator (uPA) [1, 10]. The relationship
between increase in uPA and the hemodynamic changes discussed above is not clear, but there is
literature documenting increase of uPA in several cell types including endothelial cells following
mechanical stress associated with increased turbulent flow [2, 15]. Urokinase is known to
activate matrix remodeling, seen in most tissues during wound healing and also in liver
regeneration [1].
Overall regulation of extracellular matrix during liver regeneration is a very complex
process, involving metalloproteinases and tissue inhibitors of metalloproteinases (MMP9) [9,
15]. Hepatic extracellular matrix binds many growth factors. Prominent among matrix binding
growth factors in the liver is hepatocyte growth factor (HGF) [8, 15].
A key endpoint of liver regeneration is the restoration of the total number and mass of
hepatocytes, the main functional cells of the liver responsible for delivering most of the hepatic
functions important for body homeostasis. Hepatocytes are the first cells of the liver to enter into
the cell cycle and undergo proliferation, and they produce mitogenic signals for other hepatic cell
types [15-17]. Quiescent hepatocytes in normal liver express a variety of growth factor receptors.
These include receptors for PDGF, VEGF, fibroblast growth factor receptors, c-kit [1, 6, 15].
Many growth factors and cytokines have been implicated in regulating liver regeneration. The
growth factors include hepatocyte growth factor (HGF), epidermal growth factor (EGF),
transforming growth factors (TGFs), insulin and glucagons. And the cytokines include tumour
necrosis factor TNF and interleukin IL-6. There are several individual transcription factors or
50
proteins that are required for normal liver regeneration but have not yet been associated with
specific growth-factor- or cytokine-regulated signal-transduction pathways [3, 6, 8, 15].
The studies with hepatocytes in primary culture however have shown that despite the
expression of many mitogenic receptors, the only mitogens for hepatocytes in chemically defined
serum-free media are HGF and ligands of the EGFR (EGF, TGF, amphiregulin, HBEGF, etc).
These ligands are direct mitogens [9,15].
Hepatocyte growth factor (HGF)
The view of HGF as an initiator of liver regeneration is bolstered by the fact that it is a
direct mitogen for hepatocytes, it activates its receptor very early, and it can induce most of the
changes occurring during the liver regeneration (including massive hepatic enlargement). HGF
levels in plasma increase 10- to 20-fold after hepatectomy [9, 15]. HGF injection in portal vein
of normal rats and mice causes proliferation of hepatocytes and enlargement of the liver [10, 11].
HGF in liver is produced predominantly by the stellate cells [15], but also by hepatic endothelial
cells [8].
Tumor necrosis factor (TNF)
TNF is a protein known to have a variety of effects on many cells and tissues. Contrary to
what its name implies, TNF can often have promitogenic effects on cells, depending on
conditions which regulate activation of NFkB [6, 15]. TNF is not a direct mitogen for
hepatocytes. The enhance the mitogenic effects of direct mitogens such as HGF, both in vivo and
in cell culture [9] and is mitogenic for hepatocytes with transgenic expression of TGF [10, 18].
TNF increases in plasma after partial resoction. Its cellular source is considered to be the hepatic
macrophages (Kupffer cells) but production by other cell types has not been excluded. TNF
should not be viewed as the initiator of liver regeneration, but rather as one of the many
concurrent and contributory extracellular signals that all together orchestrate the early events of
the response. TNF is also a regulator of iNOS [13], and mice with deficiency in iNOS have
defective liver regeneration [9, 25].
Epidermal Growth Factor (EGF) and Transforming Growth Factor a (TGF-a)
These two factors belong to the EGF family and share a common receptor (EGFR). EGF
is mitogenic for a variety of epithelial cells, hepatocytes, and fibroblasts, and is widely
distributed in tissue secretions and fluids. In healing wounds of the skin, EGF is produced by
keratinocytes, macrophages, and other inflammatory cells that migrate into the area. TGF-a has
homology with EGF, binds to EGFR, and shares most of the biologic activities of EGF. The
EGF receptor is actually a family of four membrane receptors with intrinsic tyrosine kinase
activity [5, 9].
Interleukin 6 (IL-6)
There is abundant literature documenting the crucial role of IL6 in initiation of the acute
phase response in hepatocytes. This is a rapid increase in production by hepatocytes of many
proteins which assist in controlling acute or chronic inflammation [3, 4]. IL6 is produced by
hepatic macrophages. IL6 is not a direct mitogen for hepatocytes and does not enhance the
mitogenic effect of other growth factors. It is, however, a direct mitogen for biliary cells [11, 15]
and it has important effects on integrity of the intrahepatic biliary tree by regulating production
of small proline-rich proteins by cholangiocytes. IL6 does increase in plasma following
hepatectomy. IL6 is probably a factor contributing to optimizing processes of the early stage of
liver regeneration, but it should not be viewed as the initiator of the process [16].
Signaling mechanisms in hepatocyte growth
Molecular studies of gene-expression cascades in the regenerating liver have provided
insights into the signalling pathways that are rapidly activated in the remnant liver post51
hepatectomy. More than 100 immediate-early gees have been identified, which are activated by
normally latent transcription factors at the transition between G0 and G1, before the onset of de
novo protein synthesis. The advent of microarrays expanded this list even further, and gene
expression profiles indicate that some genes show transient up regulation, whereas others
particularly those involved in protein synthesis and cell growth are elevated throughout the
main proliferative response in the regenerating liver [3, 11, 16].
Specific transcription factors, such as nuclear factor NF-B, signal transducer and
activator of transcription STAT3 and AP1, are rapidly activated in remnant hepatocytes minutes
after partial hepatectomy. The intracellular-signalling pathways that involve mitogen-activated
protein kinase (MAPK) and, more specifically, pERKs (phosphorylated extracellular signalregulated kinases), jun amino-terminal kinase (JNK) and receptor tyrosine kinases, are rapidly
activated according to a similar time frame, thereby providing clues to the initiating signals [3, 9,
15].
Genetic and pharmacological approaches have confirmed that regeneration is a complex
process. However, it is now possible to connect many of the proteins that are involved to two
distinct linear pathways that are either cytokine or growth-factor dependent, and to identify
regions of overlap between these two main regulatory mechanisms [2, 25]. Cytokines bind to
their cellular receptors, thereby generating intracellular signals that lead to transcription-factor
activation.
Restoration of liver mass is achieved without the regrowth of the lobes that were resected
at the operation. Instead, growth occurs by enlargement of the lobes that remain after the
operation, a process known as compensatory growth or compensatory hyperplasia. In both
humans and rodents, the end point of liver regeneration after partial hepatectomy is the
restitution of functional mass rather than the reconstitution of the original form [15, 26]
Almost all hepatocytes replicate during liver regeneration after partial hepatectomy.
Because hepatocytes are quiescent cells, it takes them several hours to enter the cell cycle,
progress through G1, and reach the S phase of DNA replication. The wave of hepatocyte
replication is synchronized and is followed by synchronous replication of nonparenchymal cells
(Kupffer cells, endothelial cells, and stellate cells).
There is substantial evidence that hepatocyte proliferation in the regenerating liver is
triggered by the combined actions of cytokines and polypeptide growth factors. With the
exception of the autocrine activity of TGF-a, hepatocyte replication is strictly dependent on
paracrine effects of growth factors and cytokines such as HGF and IL-6 produced by hepatic
nonparenchymal cells. There are two major restriction points for hepatocyte replication: the
G0/G1 transition that bring quiescent hepatocytes into the cell cycle, and the G1/S transition
needed for passage through the late G1 restriction point. Gene expression in the liver
regeneration proceeds in phases, starting with the immediate early gene response, which is a
transient response that corresponds to the G0/G1 transition. More than 100 genes are activated
during this response, including the proto-oncogenes c-FOS and c-JUN, whose products dimerize
to form the transcription factor AP-1. c-MYC, which encodes a transcription factor that activates
many different genes; and other transcription factors, such as NF-kB, STAT-3. The immediate
early gene response sets the stage for the sequential activation of multiple genes, as hepatocytes
progress into the G1 phase. Quiescent hepatocytes become competent to enter the cell cycle
through a priming phase that is mostly mediated by the cytokines TNF and IL-6, and
components of the complement system. Priming signals activate several signal transduction
pathways as a necessary prelude to cell proliferation.
Under the stimulation of HGF, TGFa, and HB-EGF, primed hepatocytes enter the cell
cycle and undergo DNA replication. Norepinephrine, serotonin, insulin, thyroid and growth
hormone, act as adjuvants for liver regeneration, facilitating the entry of hepatocytes into the cell
cycle. Individual hepatocytes replicate once or twice during regeneration and then return to
quiescence in a strictly regulated sequence of events, but the mechanisms of growth cessation
have not been established.
52
Conclusions
Experimentally, hepatocyte proliferation is blocked by the use of the chemical substances
during long-term administration. It was described an increasing number of cells with mixed
biliary and hepatocytic gene expression patterns, as well as some markers of their own [15].
These cells have been called oval cells, from the shape of their nucleus. Oval cells proliferate
intensely in the periportal areas of the hepatic lobule and they are heavily infiltrated by stellate
cells; the latter intertwine with the oval cells and produce HGF, FGF1, FGF2, and VEGF [6, 8, 9,
15]. Oval cells express both albumin and alpha-fetoprotein. The origin of the oval cells has been
much debated. A strong argument for their origin from biliary cells is their early gene expression
patterns which strongly resemble biliary cells, and the fact that biliary cells begin expressing
hepatocyte-associated transcription factors before oval cells appear. There is no histologic
observation demonstrating an oval cell population in any nonbiliary compartment in a normal
liver. Cells equivalent to oval cells, called ductular hepatocytes, are also seen in humans
during fulminant hepatitis following extensive liver injury (by chemicals, viruses, etc.) and they
are assumed to pay a role similar to oval cells in restoring hepatocyte populations.[14, 17]
It should be noted that pancreatic ductules have also been viewed as the source of
progenitor cells for both acinar cells and islet cells of the pancreas [8, 9]. In addition, in vitro
studies have demonstrated the possibility of development of hepatocytes and oval cells from
bone marrow stem cells that are functionally multipotent, capable of self-replication during
symmetric cell division and give rise to progenitor cells during asymmetric cell division, but it
was not properly identified in vivo [9]. The self-renewal is a unique property of stem cells, and
progenitor cells, which are its progenitors, proliferate and differentiate in population of somatic
cells, but are not saved in tissue. They may have one or multilinear potential, but are only able to
short-term of tissues restoration [4, 5].
Despite the fact the adult liver contains undifferentiated stem cells, these cells are not
activated either during the postnatal growth or regeneration after partial hepatectomy [15]. In
these cases, normal growth is due to proliferation of adult hepatocytes. The optional reserve stem
cells of the liver are recruiting only during functional failure when hepatocytes lose the ability to
reproduce.
References
1. Currier, A. R. et al. Plasminogen directs the pleiotropic effects of uPA in liver injury and
repair. Am. J. Physiol. Gastrointest. Liver Physiol. 2003. 284, G508G515.
2. Fausto N. Lessons from genetically engineered animal models. V. Knocking out genes to
study liver regeneration: present and future. Am. J. Physiol. 1999. 277, G917G921.
3. Fey GH, Hattori M, Hocke G, Brechner T, Baffet G, Baumann M, Baumann H,
Northemann W. Gene regulation by interleukin 6. Biochimie 1991;73:4750.
4. Heinrich, P. C. et al. Principles of interleukin (IL)-6-type cytokine signaling and its
regulation. Biochem. J. 2003. 374, 120.
5. Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in
hepatic cells through nuclear factor kappaB activation. Cell Growth Differ 1999;10:819
828.
6. Koniaris, L. G., McKillop, I. H., Schwartz, S. I. & Zimmers, T. A. Liver regeneration. J.
Am. Coll. Surg. 2003. 197634659.
7. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N.
Angiogenesisin dependent endothelial protection of liver: Role of VEGFR-1. Science
2003; 299:890893.
8. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A)
rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by
partial hepatectomy and carbon tetrachloride administration. Hepatology 1991;13:743750.
9. Michalopoulos G. K. Liver Regeneration. *J Cell Physiol. 2007 November ; 213(2): 286
300.
53
10. Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the
plasminogen activators uPA and tPA. Am J Pathol 1993;143:949958.
11. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J
Biochem 1996;119:591600.
12. Michalopoulos, G. K. & DeFrances, M. C. Liver regeneration. Science. 1997. 276, 6066.
13. Nussler AK, Di Silvio M, Liu ZZ, Geller DA, Freeswick P, Dorko K, Bartoli F, Billiar TR.
Further characterization and comparison of inducible nitric oxide synthase in mouse, rat,
and human hepatocytes. Hepatology 1995;21:15521560.
14. Satyanarayana, A. et al. Telomere shortening impairs organ regeneration by inhibiting cell
cycle re-entry of a subpopulation of cells. EMBO J. 2003. 22, 40034013.
15. Taub R. Liver regeneration 4: Transcriptional control of liver regeneration. Faseb J
1996;10:413427.
16. Taub R. Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836
847.
17. Taub, R., Greenbaum, L. E. & Peng, Y. Transcriptional regulatory signals define cytokinedependent and-independent pathways in liver regeneration. Semin. Liver Dis. 1999. 19,
117127.
18. Wheeler, M. D. et al. Impaired Ras membrane association and activation in PPARa
knockout mice after partial hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 2003.
284, G302G312.
19. . .,
. . 2008, 6, 14-21.
Introducere
Papilomavirusul infecteaz celulele epiteliale i depinde de proliferarea i diferenierea
acestora, pentru asigurarea ciclului su vital. Proteinele virale, sunt prezente iniial n celulele
epiteliele din stratului bazal, i n urma proliferrii se deplaseaz spre suprafaa epiteliului ,
mpreun cu celula gazd. Expresia proteinelor E6, E7(proteine reglarorii codificate de ADN-ul
viral) n celulele stratului bazal al epiteliului, condiioneaz intrarea celulelor infectate n faza-S
a mitozei, n care se realizeaz replicarea genomului viral. Amplificarea genomului viral este
obligatorie, i condiioneaz producerea virionilor infectani. Acest fenomen este unul complex
i depinde de co-expresia mai multor proteine virale care mediaz procesul de sintez.
Componentele proteice structurale ale capsidei virale, sunt evidente n celulele ce conin o alta
protein reglatorie, i anume proteina E4, dar de data aceasta n straturile superioare ale
epiteliului. Sincronizarea acestor evenimente variaz n dependen de tipul virusului
infectant,compatibilitatea lui cu celula gazd i respectiv ne determin s stabilim caracterul i
severitatea neoplaziei or faza productiv a virusurilor depinde dramatic de tipul virusului i
epiteliul infectat n funcie de specie. Nesincroinizarea dintre tip i specie conduce la apariia
infeciilor abortive.
Tipuri de papilomavirusuri umane (HPV)
Papilomavirusurile sunt incluse n mai multe grupuri. Ele pot infecta mai mult de 20 de specii
de psri i reptile. Datorit faptului c HPV reprezint o importan deosebit n aspect medical,
au fost studiate mai mult de o sut tipuri de virusuri cunoscute la moment [5]. Dei clasificarea
papilomavirusurilor a fost stabilit n funcie de nucleotidele omoloage din ADN-ul lor, ntre
diferite grupuri evolutive, este reflectat o similitudine n structura acestora. HPV -ul transmis pe
cale sexual, este inclus n supergrupul A (cunoscut ca Alpha papillomavirus) [17]i virusurile
din acest grup cum ar fi HPV6 i HPV11, provoac patologii sexual transmisibile majore la 1%
din populaia sexual activ. Aceste virusuri pot deasemenea infecta site-uri orale, unde ei sun
asociai n general cu papiloamele benigne. Prin contrast, virusurile din supergrupul A, cum ar fi
HPV16, HPV18 cauzeaz leziuni ale mucoaselor ce pot progresa n neoplazii cu risc nalt de
malignizare i cancer [6]. Dei virusurile din supergrupul A includ tipuri ce au tropism pentru
site-urile cutanate, cum ar fi HPV2 sau HPV10, particularitile comune ale ciclului vital nu se
extind asupra papilomaviruior din aceai grup evolutiv [33]. HPV2 i papilomaviruii
nrudii din supergrupul A, sunt facorii primari ce cauzeaz apariia verucilor.
Grupul scundar major al HPV, este inclus n supergrupul B. Virsurile din subgrupul B1, cum
ar fi HPV5 (Beta papillomavirus) [17] cauzeaz infecii inaparente sau latente n populaia
general, dar poate deveni o problem la indivizii imunosupresai i la cei cu patologii ereditare,
care-i fac susceptibili la infecii cu papilomavirusuri din subgrupul respectiv, i al supergrupului
B. Asfel de pacieni pot dezvolta cancer de piele n urma infeciei cu HPV, i se consider c i
beta papilomavirusul poate fi implicat n dezvoltarea cancerului de piele non-melanomic
(NMSK) n populaia general[29]. Virusurile din subgrupul B2 cum ar fi HPV4 (Gamma
papillomavirus); [17]cauzeaz verucile cutanate n populaia general care pot s se asemene
superficial cu cele cauzate de papilomavirusurile din supergrupul A, cum ar fi HPV2.
Grupul rmas a HPVs- cu risc nalt sunt incluse n supergrupul E. Doar trei virusuri ce
afecteaz specia uman din acest grup sunt cunoscui, i toi cauzeaz papiloma cutanat n
populaia general. HPV1 este cel mai puin studiat virus din acest grup i ca i HPV2 din
supergrupul A cauzeaz veruci i nevi palmari.
Problemele n dezvoltarea modelului general a bolii asociate cu HPV
Din cele expuse mai sus reese c diferite HPV-uri sunt implicate n suplinirea diferitor nie
biologice i c n acela mod virusurile din diferite clase evolutive pot fi abile s inteasca
aceleai site-uri epiteliale. Nectind la heterogenitatea aparent, ntre tiputile de HPV,
caracteristicele lor comune le permit s produca virioni infectani n celulele epiteliale infectate,
indiferent de specie. Toate HPV-urile cunoscute sunt n exclusivitate epiteliotrope, i spre
deosebire de anumite tipuri de papilomavirusuri animale, cum sunt BPV1, BPV2 ele nu
55
infecteaz i nu conin expresia produsului genelor n dermul subiacent. Similar, toate produc
particule infectante n straturile epiteliale superioare dei ele sunt diferite ca i expresie,
depinznd de sinteza virusului, i vor fi transmise prin contact direct (nevi genitali) sau indirect
(veruci)[33]. Cunoscnd la general cum papilomavirusurile privoac boala, devine evident
faptul c fonul volutiv al diferitor virusuri, site-ul lor de infectare i modul lor de transmitere,
necesit ateie dac modelul general urmeaz s fie aplicat n particular, pe anumite tipuri de
HPV. Diferenele n secvenele reglatorii i potenialul de codificare ale genomului viral sunt
destul de clar studiate n biologia diferitor virusuri din acest grup.
Organizarea HPV (ciclul vital)
Un interes deosebit n ultimele decenii a fost acordat studierii, i scoaterii n eviden a
caracteristicilor HPV16, ce este agentul cauzal al cancerului de col uterin.
Iniial virusul necesit acces la celulela stratului bazal , unde poate ajunge prin defectele
epiteliului supraiacelt. Astfel de defecte pot sa nu fie evidente, i pot aparea n condiiile n care
epiteliul este supus microtraumelor.
Pentru ca o leziune s fie meninut, virusul trebuie s infecteze celulele bazale (stem) ale
epiteliului[21]. n epidermul pielii astfel de celule se gasesc din abunden n foliculii pieloi, i
pentru virusurile din supergrupa B1, foliculii pieloi pot fi un important site de infectare sau
poart de intrare. Mai multe studii au artat ca ADN-ul viral din BPV1 poate fi amplificat prin
PCR, n rezultatul prelevrii epiteliului infect din folicolii pieloi [7]. Pentru HPV16 formarea i
meninerea leziunilor cervicale, este facilitat de migrarea celulelor infectate ale epiteliului
stratificat pavimentos n zona de transformare, unde formeaz stratul bazal. Exist receptori la
suparafaa celulei care permit ataarea virusului de membrana celular, dei mai multe studii
denot dependena atarii, de implicarea n acest proces a heparan sulfatului[27]. Este
demonstrat c internalizarea (patrunderea in celul) virionilor ataai, este un proces lent cu
perioada de njumataire de o or, i se produce prin endocitoza virusului prin vezicule ce sunt
consolidate de complexul proteic Clatrin-trickeleon [11].
Decapsidare papilomavirusului este rezultatul scindarii conecsiunilor intracapsometrice a
sapsidei virale, la nivelul membranei celulare, urmnd ca ADN-ul viral s fie transportat n
nucleu.
Meninerea genomului viral
Este demonstrat c dezvoltarea ulterioar a infeciei, se datoreaz meninerii genomului viral
n celul, care este determinat de prezena unui numr stabil de episomi n celulele stratului
bazal al epiteliului pluristratificat scuamos necornificat. Responsabile de meninerea ADN-lui
viral ca i episomi n respecrivele celule, se fac proteinele virale reglatorii E1 i E2 care
faciliteaz segregrea corect a genomului pe parcursul diviziunii celulei gazd. Insuficiena
expresiei genei ce codific pentru E1, nu permite meninerea episomilor[24]. Se presupune c
genomul viral este pastrat n celulele stratului bazal al epiteliului, ntr-un numar de aproximativ
10-200 de copii per celula, i c aceste proteine precoce (E6, E7,E1i E2) sunt exprimate n
straturile celulare inferioare ale epiteliului[16]. Aportul proteinelor E6 i E7 n proliferarea
celulelor bazale, n cadrul infeciei in vivo, la moment este incert, dar este cert faptul c prezena
proteinelor reglatorii E1 i E2, sunt suficiente pentru meninerea episomilor virali n celulele
stratului bazal al epiteliului.
Faza proliferariv
n epiteliul neinfectat, celulele bazale divizndu-se se deplaseaz in stratul suprabazal, unde
sunt supuse transformarii terminale. Schimbarile includ transformarea fizica a filamentelor
intermediare constituite din cheratina, cu formarea anvelopei epiteliale cornificate, i secreia
lipidelor, care impreuna formeaza o bariera fizica, ce protejeaza de aciunea factorilor mediului
extern.
n infecia cu papilomavirus, E7 i deasemenea E6 se exprim n aceste celule, astfel nct
ciclul celular este ncetinit, iar diferemierea terminal a celulelor epiteliale stagnat. Se
consider c E6 i E7 i desfaoar aciunea concomitent pentru a realiza aceste efecte (inclusiv
i n leziunile cauzate de infecia HPV cu risc inalt precum HPV16), ele fiind doua proteine ce
56
i aceasta din cauza c promotorul tardiv este activ pe tot parcursul ciclului viral productiv.
Modelele recente sugereaz c la o cretere modest a activitaii promotorilor tardivi pe
parcursul diferenierii celulare, poate duce i la creterea expresiei E1 i E2 (deasemenea E4 i
E5), i ca i consecin - creterea numarului de copii ale genomului viral. Noul material genetic,
primit n urma replicrilor, servete drept machet pentru ulterioara expresie a E1 i E2,
facilitnd la rindul su, amlificarea adiional a genomilor virali [33].
Sinteza virusului
Papilomavirusurile codifica dou proteine structurale, care se exprima n straturile superioare
a esutului infectat, ce se produce conconitent cu finisarea procesului de amplificare a
genomului. L2 reprezit o protein structural minor care ca i L1 este produs de subgrupul de
celule care exprima E4 [19][20]. Proteina capsidic majora L1, este evideniat dup expresia
L2, ceea ce denot asamblarea particulelor infecioase n straturile superioare ale epiteliului [23].
Particulele papilomavirusului conin aproximativ 8000 de perechi de baze in genom, pe cnd o
capsida conine 360 de copii a proteinei L1 i 12 copii de L2, organizate in 72 de capsomere.
Proteina L2 acumuleaza structuri globulare cunoscute ca i corpusculuii PML pe parcursul
asamblrii virusului (posibil prin asocierea cu transcrierea factorului Dax) asamblind proteina
majora L1 n domenii. Se presupune c corpusculii PML pot fi site-uri de replicare a ADN-ului
papilomaviruilior [15] i aceste proteine capsidice se acumuleaz pe aceste site-uri, facilitind
mpachetarea. Dei pariculele virale por fi asamblate n absena L2, proteina L2 sporete
mpachetarea virionilor i virulena lor. Din acest moment virusul trebuie s evadeze eventual
din celula epitelial infectat, i s supraveuiasca extracelular, nainte de reinfectare.
Papilomavirusurile nu sunt litice, i nu sunt eliberate pn cnd celulele infectate nu ajung la
suprafaa epiteliului [9][10]. Odat cu deplasarea celulelor spre straturile superficiale ele
epiteliului, o eventuala retenie n aceste celule a atigenilor papilovavirusurilor, pot compromite
detectarea imun a virusului, datorit faptului c virusul de obicei posed mecanisme moleculare
care limiteaz prezentarea epitopilor virali, celulelor imunocompetente, ncepnd din straturile
inferioare ale epiteliului[3]. Dei expresia proteinelor virale pot inhiba expresia diferenierii
marcherilor, prevenind cornificarea scuamoas obinuit [19][20], este bine cunoscut faptul c
proteina viral E4, poate contribui direct la ieirea virusului din celulele straturilor epiteliale
superficiale, dup perturbarea asamblrii cheratinei [19][20] i afectarea organizrii inveliului
scuamos cornificat [9][10].
Organizarea ciclului vital la diferite tipuri de HPV
Dei toate papilomavirusurile trebuie s urmeze cascada evenimentelor descrise mai sus, n
ordinea producerii virionilor infectani, diferite strategii a infeciei productive sunt aparente ntre
diferite grupuri evolutive. Papilomavirusurile umane din supergrupul B2, precum HPV4, nu
conin site-ul LXCXE necesar pentru asocierea cu pRb i proteina comun E7, presupunind c
la nivel molecular ele pot opera diferit n comparaie cu papilomavirusurile supergrupului A,
cum ar fi HPV2, care cauzeaz leziuni n locuri similare. n acela mod, proteina E4 a HPV4
previne polimerizarea monomerilor keratinei, n celulele epiteliale din sraturile superficiale, de
rnd cu aceeai protein produs de HPV1(supergrupul E) i HPV2 (supergrupul A) [19][20],
favorizind ieirea virusului din celulele epiteliale scuamoase cornificate. Analizele comparative a
papilomavirusurilor de diferite tipuri, au demonstrat c segmantele de ADN viral ce codific E1
i L1 sunt cele mai conservate[17]. Se pare ca aceste gene sunt fundamentale i indispensabile
pentru supraveuirea papilomavirusurilor. Nectnd la diversitatea papilomavirusurilor, se pare c
virusurile din grupele evoluive relatate, dispun de anumite similaritai. Acestea pot fi ilustrate
dup compararea papilomavirusurilor coninui n supergrupul E (cum ar fi HPV1) care
mpreuna cu cei din supergrupul A (HPV2), provoac apariia verucilor. n primul grup care
include papilomavirusul oral canin (COPV), amplificarea genomului ncepe cu att mai devreme
cu ct celulele parasesc stratul bazal, fr intervenirea caracteristic a fazei proliferative a
virusurilor aa precum HPV2 sau HPV11[33]. S-a speculat ca aceste divergene pot argumenta
existena cilor diferite de transmitere a diferitor tipuri de HPV, i necesitatea de a produce un
numar suficient de particule virale care s permit infectarea far stimularea sistemului imun.
58
12. Coleman N, Birley HDL, Renton AM, Hanna NF, Ryait BK, Byrne M,et al.
Immunological events in regressing genital warts. Am J Clin Pathol 1994;102:76874.
13. Crum CP, Nuovo G, Friedman D, Silverstein SJ. Accumulation of RNA homologous to
human papillomavirus type 16 open reading frames in genital precancers. J Virol
1988;62:8490.Culp TD, Christensen ND. Kinetics of in vitro adsorption and entry
ofpapillomavirus virions. Virology 2004;319:15261.
14. Day PM, Lowy DR, Schiller JT. Papillomaviruses infect cells via aclathrin-dependent
pathway. Virology 2003;307:111.
15. Day PM, Roden RBS, Lowy DR, Schiller JT. The papillomavirus minorcapsid protein,
L2, induces localization of the major capsid protein, L1, and the viral
transcription/replication protein, E2, to PML oncogenic domains. J Virol 1998;72:142
50.
16. De Geest K, Turyk ME, Hosken MI, Hudson JB, Laimins LA, WilbanksGD. Growth and
differentiation of human papillomavirus type 31bpositive human cervical cell lines.
Gynecol Oncol 1993;49:30310.
17. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H.Classication of
papillomaviruses. Virology 2004;324:1727.
18. Doorbar J. The E4 proteins and their role in the viral life cycle. In: Lacey C, editor.
Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds Medical
Information, Leeds University Press; 1996. p. 318.
19. Doorbar J, Ely S, Sterling J, McLean C, Crawford L. Specic interaction between HPV16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate lament
network. Nature 1991;352:8247.
20. Doorbar J, Foo C, Coleman N, Medcalf E, Hartley O, Prospero T, et al. Characterisation
of events during the late stages of HPV16 infection in vivo using high afnity synthetic
fabs to E4. Virology1997;238:4052.
21. Egawa K. Do human papillomaviruses target epidermal stem cells? Dermatology
2003;207:2514.
22. Fehrmann F, Klumpp DJ, Laimins LA. Human papillomavirus type 31E5 protein
supports cell cycle progression and activates late viral functions upon epithelial
differentiation. J Virol 2003;77:281931.
23. Florin L, Sapp C, Streeck RE, Sapp M. Assembly and translocation ofpapillomavirus
capsid proteins. J Virol 2002;76:1000914.
24. Frattini MG, Lim HB, Laimins LA. In vitro synthesis of oncogenic human
papillomaviruses requires episomal genomes for differentiationdependent late gene
expression. Proc Natl Acad Sci 1996;93:30627.
25. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. Inhibition of CDK
activity and PCNA-dependent DNA replication byp21 is blocked by interaction with the
HPV16 E7 oncoprotein. Genes and Development 1997;11:2090100.
26. Genther SM, Sterling S, Duensing S, Munger K, Sattler C, Lambert PF.Quantitative role
of the human papillomavirus type 16 E5 gene duringthe productive stage of the viral life
cycle. J Virol 2003;77:283242.
27. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M. Human papillomavirus infection
requires cell surface heparan sulfate. J Virol2001;75:156570.
28. Gross GE, Barrasso R, editors. Human papillomavirus infection: a clinical atlas. Berlin:
Ullstein Mosby; 1997.
29. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, et al. Increased
risk of skin cancer associated with the presence of epidermodysplasia verruciformis
human papillomavirus types innormal skin. Br J Dermatol 2004;150:94957.
30. Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical
aspects. In: zur Hausen H, editor. Human pathogenic papillomaviruses. Heidelberg:
Springer-Verlag; 1994.
61
31. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, et al. The L1 major
capsid protein of human papillomavirus type11 recombinant virus-like particles interacts
with heparin and cellsurface glycosaminoglycans on human keratinocytes. J Biol Chem
1999;274:581022.
32. Knowles G, ONeil BW, Campo MS. Phenotypical characterization of lymphocytes
inltrating regressing papillomas. J Virol 1996;70:84518.
33. Middleton K, Peh W, Southern SA, Grifn HM, Sotlar K, Nakahara T, et al. Organisation
of the human papillomavirus productive cycle during neoplastic progression provides a
basis for the selection of diagnosticmarkers. J Virol 2003;77:10186201.
62
Material i metode
Anatomia variabilitii individuale, n funcie de vrst i sex, a plexului lienal, precum i a
splinei a fost studiat prin metoda de disecie macroscopic fin, propus de . . i
. . .
Pentru stabilirea frecvenei splinei accesorii n aspect clinic, au fost analizate 257 de
tomograme n Centrul Naional tiinifico-Practic n Domeniul Medicinii de Urgen. Rezultatele
au fost analizate prin metode statistice, n funcie de particularitile de vrst i sexul
pacienilor, i prelucrate cu ajutorul programei Excel. Au fost calculai parametrii de rspndire a
structurii i raportul lor, iar veridicitatea rezultatelor a fost bazat pe calcularea criteriului tstudent par. Sistemul vascular al splinei a fost examinat prin analiza a 106 de panaortograme.
Rezultate i discuii
Splina este situat n hipocondrul stng al cavitii abdominale, la nivelul coastelor IX
XI, n loja splenic cuprins ntre diafragm, stomac, coada pancreasului, unghiul stng al
colonului i rinichiul stng. La splin distingem: faa diafragmatic, convex orientat spre
diafragm; faa visceral, concav, neregulat ce comport hilul lienal prin care ptrunde artera
lienal, nervi i ies vena lienal. Organul are o lungime de 12 14 cm, lime de 8 cm, grosime
de 4 cm. Volumul i masa splinei variaz n dependen de activitatea hematopoietic i de
cantitatea de snge depozitat.
Dimensiunile splinei au fost studiate la adolesceni i maturi (tab. 1, 2), i n dependena de
sex (tab. 3, 4).
Tabelul 1. Dimensiunile splinei la maturi
Din literatura
M0 ES0 mm
132,3 8,06
86,3 4,72
Lungimea
Limea
Studiul propriu
M1 ES1 mm
106,2 2,32
45,8 1,62
3,11
8,11
< 0,01
< 0,001
Lungimea
Limea
Studiul propriu
M1 ES1 mm
85,5 1,37
46,8 0,85
4,29
0,27
< 0,001
> 0,05
Brbai
Abs.
5
8
32
10
55
Femei
X1 ES1 mm Abs.
85,3 0,7
9
102,7 0,4
17
106,6 0,3
5
114,8 0,08
21
9
102,3 0,2
101
63
X2 ES2 mm
85,7 0,03
108,2 0,6
4 107,4 0,2
0,57
7,64
13,06
100,0 0,3
106,8 0,2
101,6 0,3
47,74
534,0
1,94
p
>0,05
<0,001
<0,001
<0,001
<0,001
>0,05
Femei
Grupele
de vrst
t
p
Abs.
X1 ES1 mm Abs.
X2 ES2 mm
VII gr.
5
47,7 0,9
9
46,0 0,8
1,42
>0,05
VIII1 gr.
8
46,5 0,8
17
44,5 0,7
1,82
>0,05
VIII2 gr.
32
46,7 0,8
45
45,8 0,6
0,9
>0,05
IX gr.
10
57,1 0,6
21
43,8 0,5
17,05
<0,001
X gr.
9
43,5 0,9
48,3
<0,001
Total
55
49,5 0,7
101
44,7 0,7
4,85
<0,001
*
Not : Repartizarea materialului investigat conform perioadelor ontogenezei are la baz
periodizarea de vrst adoptat la Simpozionul Institutului de fiziologie de vrst a AP URSS
(dup . . (1969), . . , . . (1991), precum i cea propus
de R. Robacki (citat dup M. tefane et al., 2000). Femei : VII 16-20 ani, VIII1 21-35 ani,
VIII2 - 36-55 ani, IX 56-74 ani, X 75-90 ani. Brbai: VII 17-21 ani, VIII1 22-35 ani,
VIII2 -36-60 ani, IX 61-74 ani.
Conform datelor obinute lungimea organului n funcie de sex nu are diferena
semnificativ n total. Diferena exist n grupa IX perioada presenil (56-74 ani femei i 6174 ani brbai) (tab.3). Limea splinei n funcie de sex are n total diferena semnificativ (t =
4, 85) i n grupa IX de vrst 17, 05 (tab. 4).
Nu exist opinie unic despre forma splinei. Rezultatele cercetrilor permit a considera c
forma splinei este supus unor modificri individuale, ce reprezint reflectarea unor pronunate
varieti n forma organului n procesul ontogenezii. Diversitatea formelor splinei poate fi
explicat prin dezvoltarea necoerent a organului i prin influena dimensiunilor, formei
organelor vecine.
A fost studiat forma splinei n diferite perioade a ontogenezei. Conform cercetrile
noastre, formele principale ale splinei sunt: alungit, rotund i intermediar. Au fost stabilite
diferenele semnificative statistice (p < 0, 05) dintre forma splinei alungit i intermediar la
brbai i femei (tab. 5). Nu a fost depistat nici un caz cu forma splinei rotund.
Tabelul 5. Frecvena tipurilor formei splinei n funcie de sex
< 63 %
alungit
63,0 - 75,0%
intermediar
76,0% >
rotund
Abs.
26
29
-
Brbai, n = 55
P ES%
47,3 5,35
Abs.
220
52,7 4,28
112
Femei, n = 32
P ES%
62,5 5,19
22,03
<0,05
37,5 4,02
22,58
<0,05
--
chirurgicale n zona respectiv prin faptul c ele trebuiesc cunoscute i luate n calcul n
medicina practic.
Analiza rezultatelor a demonstrat c n 44, 5% din cazuri (36 de observaii) artera
lienal avea un traiect rectiliniar. n 27 de cazuri (33, 3%) traiectul ei era puin sinuos. n alte 18
(22, 2%) cazuri specificul traiectului arterei lienale const n aceea c ea prezenta dou trei
segmente n form de spiral, cu o distan ntre ele de 2 4 cm. Din acest numr de observaii
18, 72,2%, ceea ce constituie 13 cazuri, au fost depistate la persoanele care depise vrsta de 60
de ani. n aa mod, constataia capt statut de legitaie: cu ct vrsta subiecilor este mai
naintat, cu att traiectul arterei lienale devine mai sinuos.
Artera lienal, la originea sa (segmentul incipient) de cele mai multe ori 65 (80,3%)
de observaii, formeaz un unghi ascuit cu trunchiul celiac; n restul cazurilor 16 (19,7%)
unghiul respectiv se apropie de 90.
Sediul topografic al arterei lienale n raport cu pancreasul variaz mult. n majoritatea
cazurilor artera lienal corespunde marginii superioare a pancreasului, avnd o orientare spaial
mai aproape de orizontal. Varianta n cauz a fost nregistrat n 44 (54, 4%) cazuri. n cazurile
n care traiectul vasului dat este sinuos, unele segmente vasculare devin supraiacente
pancreasului. n cazurile n care artera dispune de traiect rectiliniar, topografic, n mare parte ea
corespunde marginii superioare a pancreasulu. Cnd direcia ramificrilor arterei lienale cu
direcia ei pn la ramificare formeaz unghiuri aproape drepte, unele ramificri sunt direcionate
descendent. Frecvena variantei date a constituit 12, 3% (10 cazuri). Artera lienal era amplasat
din posteriorul marginii superioare a pancreasului n 9 (11, 1%) cazuri, iar pe faa anterioar a
corpului pancreatic n 2 (2, 5%) din cazuri. Merit atenie, inclusiv din punct de vedere clinic,
varianta n care artera lienar era ancorat, parial sau n totalitate, n grosimea parenchimului
pancreatic; frecvena variantei n cauz a constituit 16 (19, 7%) observaii din totalitatea
cazurilor.
[6], avnd 850 de observaii proprii, au stabilit c n 95% din cazuri artera lienal,
topografic, corespundea marginii superioare a pancreasului, n restul observaiilor (5,0%) vasul
avea sediu retropancreatic. n 2 (0, 23%) din cazurile analizate de autorii citai vena lienal era
poziionat din faa arterei omonime.
n literatura de domeniu, n aspect aplicativ, artera lienal este descris n funcie de
segmente; ele prezint interes n intervenii chirurgicale pe spin, pe pancreas sau pe nsui
arter. n legtur cu separarea arterei lienale si aplicarea ligaturilor la diferite niveluri, [13]
descriu segmentele proximal, mediu i distal ale vasului n cauz. Sub acelai unghi de vedere,
[10] divid artera lienal n patru segmente relativ bine conturate. Este vorba de: segmentul iniial
urmeaz de la trunchiul celiac pn la corpul pancreasului, cu sediu supraiacent marginii
superioare a pancreasului i o lungime de 2 3 cm. El se afl n grosimea unui strat celular lax
perivascular. Segmentul incipient poate absenta n cazurile n care artera lienal formeaz un
unghi drept cu trunchiul celiac, el avnd traiect paralel i mai sus marginii superioare a
pancreasului.
Printre materialele proprii am nregistrat un caz n care distana dintre trunchiul celiac
i pancreas era foarte mic. Raporturile spaiale erau de aa ordine, nct artera lienal avea
originea n parenchimul glandular. n aa mod, artera era amplasat intraglandular pe un traiect
de 4,5 cm, la o adncime de 1,0 cm n raport cu faa anterioar a organului. Deci separarea
arterei a dus la o distrucie a parenchimului glandular, ceea ce are consecine clinice grave n
intervenii operatorii att pe pancreas, ct i pe artera lienal. Revenind la cazul n descriere,
trebuie menionat c, respectiv corpului pancreasului, artera i vena lienale pe un traseu de 4,0
cm erau ancorate ntr-un nule de sut glandular la nivelul marginii superioare a pancreasului.
La limita dintre corp i coad, artera lienal lanseaz ramura polar inferioar, iar trunchiul
arterial, prinr-o curbur moderat, urmeaz n sens ascendent spre hilul lienal.
Al doilea segment vascular corespunde corpului pancreasului, el are o lungime de 8
10 cm. Sediul arterei lienale difer: el poate fi intrapancreatic, pe feele anterioar sau
posterioar, sau pe marjinea superioar a pancreasului. Separarea arterei de suturile
67
nconjurtoare este dificil, inclusiv din cauza ramusculelor scurte, responsabile de nutriia
glandular, cu att mai mult n cazurile sediului ei intravisceral.
Rezultatele actualului studiu au demonstrat c n 81, 5% din cazuri (66 de observaii)
artera lienal era plasat pe faa anterioar a cozii pancreasului, n timp ce n 16, 0% din cazuri
(13 obiecte) ea era poziionat pe faa posterioar a aceleiai poriuni pancreatice. Mai rar 2,
5% din cazuri (2 observaii), a. lienalis se afla supraiacent la cauda pancreas. Segmentul
respectiv al arterei splenice nu totdeauna este reprezentat de un trunchi unic. Remarcm acest
fapt din considerente clinice, el se refer la modalitatea ramificrii a. lienalis. O alt remarc de
ordin topografic: n unele cazuri primele trei segmente ale arterei lienale sunt poziionate cu 1, 5
cm mai sus de marjinea superioar a pancreasului.
Segmentul prehilar reprezint poriunea a. lienalis dintre coada de pancreas i hilul
lienal. Noi am studiat acest segment vascular pe 111 obiecte. Lungimea lui variaz ntre 1 i 5
cm, fiind amplasat n grosimea ligamentului pancreatolienal. Segmentul prehilar al a. lienalis,
din punct de vedere structural, se caracterizeaz prin prezena multiplelor ramificri ntreesute
cu vase venoase. Referitor la segmentul prehilar [2], relatau c el dispune de lungime medie
egal cu 1,5 cm, care variaz de la caz la caz n limitele 0,3 4,5 cm.
Locul i modalitile de ramificaie ale arterei lienale sunt diferite i variaz mult.
Cercetrile arat c deseori artera se ramific la nivelul cozii pancreasului ori ntre foiele
ligamentului pancreatolienal. Odat cu implicarea chirurgilor n rezecia diferitelor poriuni ale
splinei n caz de traumatisme, maladii benigne i alotransplantri a hemisplinei de la un donator
nrudit viu, foarte esenial a devenit nelegerea diviziunii anatomice a lobilor i segmentelor
acestui organ. Pentru diferite vase i segmente splenice nu exist o nomenclatur unic, se cere
n primul rnd o descriere preliminar.
Artera lienal n 90% din cazuri (100 de obiecte) se ramific dihotomic n ramuri de
ordinul I superioar i inferioar. Prima din ele mai frecvent avea diametrul mai mare, se
ndrepta spre polul superior/posterior ale splinei, iar a doua la polul inferior/anterior.
Unghiurile ramificaiei acestor vase sunt solitar diferite. n 67 (60, 3%) cazuri arterele se
ramificau sub un ungi ascuit i se apropiau de splin n treimea medie a hilului. Mai frecvent
36 (53, 7%) cazuri jumtatea superioar a splinei era vascularizat cu participarea ramurilor
arterei superioare, iar cea inferioar din contul arterei inferioare. n 23 (34, 3%) de cazuri
persista o variant de vascularizare a splinei, cnd artera inferioar vasculariza 2/3 inferioare a
parenchimului organului, iar restul splinei rmnea pe contul arterei superioare. Mai rar, 8 (12%)
cazuri, n 2/3 superioare ale splinei se ramifica artera superioar, iar n 1/3 inferioar artera
inferioar cu ramificaii mai reduse la numr.
Numai n 33(29,7%) de cazuri arterele destul de evident se deviau spre polurile splinei
ramificnduse sub un unghi obtuz. Ramificaia avea loc la o distan de pn la 4 5cm de la
hilul splinei, sau cu formarea unui peduncul scurt n apropierea splinei.
Artera lienal n 8 (7, 2%) cazuri se ramifica n 3 ramuri de ordinul I care urmau ctre
polii i poriunea central a organului.
Clasificarea lobilor i segmentelor splinei este prezentat diferit n literatura de
specialitate. Dup [9], artera splenic se divide n dou ramuri lobare: artera splenic superioar
i artera splenic inferioar, dar nu a fost nregistrat a treia arter lobar.
Numai ntr-un caz (0, 9%) artera lienal era ramificat n 5 artere de ordinul I. Forma
magistral, cnd a. lienalis n hil se ndrepta spre polul inferior, dnd concomitent de la 5 pn la
7 ramuri, a fost nregistrat n 2 (1,8%) cazuri.
O alt abordare de clasificare a ramificaiei arterei lienale are loc n baza ramurilor
vaselor hilare. Artera splenic bifurcat sub un unghi ascuit la distana de hil ntre 3 i 7 cm
capt aspectul literei Y culcat. Aa configuraie a vasului era observat pe majoritatea
pieselor disecate 67 % din cazuri. Numai n 33 % bifurcaia vasului avea loc n apropierea
hilului lienal (distana pn la 3, 0 cm), sub un unghi obtuz. Forma vasului amintea litera T
[8], descriu peduncul splenic scurt (2, 5 3, 0 cm) n 9% din cazuri (10 piese). Artera splenic se
bifurc n apropierea hilului, unghiul dintre cele dou ramuri fiind obtuz, apropiat valorii de
68
180, conferindu-i aspectul literei ,,T. n tipul peduncul lung se ncadreaz arterele splenice
bifurcate la distana de hil ntre 3 i 6 cm. Aspectul ramificrii vasului fiind al unei litere ,,Y
culcat. Aceast configuraie a fost observat la majoritatea pieselor disecate 91% (110 piese).
n 40 (36, 1%) de cazuri de la artera lienal, pn la ramificarea n ramuri de ordinul I
se desprinde o arter care urmeaz la unul din polii splinei. Mai des era ntlnit artera polar
inferioar 21 (52, 5%) de cazuri.
Nemijlocit de la trunchiul arterei lienale ea pornete n 16 (76, 2%) cazuri, iar de la
ramura inferioar de ordinul I n 5 (23, 8%) cazuri. Artera polar inferioar are arhitectur mai
complicat. n 15 cazuri ea pornete printr-un trunchi comun cu artera gastroomental stng. n
3 cazuri avea un trunchi comun cu artera gastroomental stng i cu ramura cozii pancreasului,
i numai ntr-un caz cu ramura splinei accesorii.
Artera polar superioar a fost depistat pe 14 (35%) piese anatomice. Mai des ea se
desprinde de la un trunchi al arterei lienale 11 (78, 5%) cazuri (fig. 29); mai rar 3 (21, 5%)
cazuri de la ramura superioar de ordinul I (fig. 30).
Numai n 5 cazuri (12, 5%) arterele polare se ramifica pentru ambii poli al splinei. Mai
rar 3 cazuri (60 %) arterele polare erau dublate.
Ramurile arterei lienale de ordinul I, II, III, n zona hilului splinei, au diverse raporturi
topografice, care determin aspectul arhitectonic al sistemului vascular arterial. Fiecare din
ramurile primare (de ordinul I) poate s se ramifice dihotomic sau lanseaz 3 4 ramificri de
ordinul II; ele duc la apariia unui complex vascular, de la care, n funcie de particularitile
individuale ale subiecilor, n parenchimul splinei ptrund de la 2 pn la 17 ramuri. De cele mai
dese ori capsula organului este penetrat de 6 10 ramuri arteriale de ordinul II i III. Cele din
urm pot fi asociate i cu ramificri de ordinul IV V. Din aceste considerente ligatura arterei
lienale n zona hilar ntlnete dificulti de ordin tehnic, totodat, scade eficiena ei.
Sistemul vascular al splinei poate fi examinat i prin intermediul panaortografiei. Ea
permite a stabili sursele de vascularizaie ale splinei, traiectul, modul i locul de ramificare a
arterei lienale, inclusiv tipul de ramificaie, corelaiile spaiale cu alte vase ale cavitii
abdominale, traiectul i amplasarea ramurilor arterei lienale de diferit ordin. Informaia de acest
gen prezint interes aplicativ la stabilirea diferitelor procese patologice ale organului.
Panaortografia permite stabilirea pe viu a tuturor jaloanelor sistemului vascular, a variantelor lor
de structur i corelaiile spaiale n parenchimul organului.
n aa mod au fost analizate 106 de panaortograme. Artera lienal a avut traiectul
spiralat n 40 (37, 8%) de cazuri; n 39 (36, 7%) cazuri ea despunea de un traiect rectiliniu. n
alte 25, 5% din cazuri (27 observaii) traiectul a. lienalis era uor sinuos. La 59 (55, 7%) dintre
subieci, n zona hilar artera lienal se ramifica dihotomic; trifurcaia ei a fost stabilit n 19 (17,
9%) cazuri. De remarcat o alt variant: artera lienal ptrundea n parenchimul lienal sub forma
unui singur trunchi, variantei n cauz i-au revenit 28 (26, 4%) cazuri.
Prin analiza angiogramelor autorii [16], au stabilit c n 7, 5% din cazuri a. lienalis
intr n zona hilar sub forma unui singur trunchi; n alte 46% din cazuri ea se bifurc dac nu n
zona hilar, apoi n apropierea ei. Trifurcaia arterei lienale a fost observat n 36% din cazuri,
tetrafurcaia n 4, 8% din observaii. Autorii citai relateaz prezena pentafurcaiei n 4% din
cazuri, iar n 1, 7% artera lienal lansa 6 i mai multe ramuri.
Anastomozele arterei lienale pot fi grupate n intrasistemice i intersistemice. Ele
asigur afluxul sangvin suficient al splinei n cazurile deconectrii trunchiului principal sau a
ramurilor mari. Totodat, mult depinde de locul aplicrii ligaturii arteriale sau de sediul
trombilor sau a altor factori care obstacoleaz circulaia sangvin n zona respectiv.
Rolul anastomozelor intrasistemice ale arterei lienale este mai puin important
comparativ cu anastomozele intersistemice. Analiza materialului propriu ne permite s ne
referim la anastomozele intrasistemice ale arterei lienale. Ele, totodat, se pot forma i cu
participerea ramusculelor cu genez din alte surse arteriale adiacente, devenind concomitent
anastomoze intra- i intersistemice.
69
cazuri vena lienalis, n apropierea hilului splinei, este format din 3 ramuri venoase, 2 dintre care
vin de la poluri i una din centrul organului. Uneori (0, 9%) poate avea loc formarea venei
lienale prin fuzionarea a 5 vene, dou dintre care dreneaz partea central. n 1, 8% din cazuri
vena lienal era format n regiunea polului superior, trecea pe faa visceral a splinei, cu
formarea unui arc spre hilul organului. n vena lienal se vrsa 5 6 vene de ordinul I.
Locul de confluere al ramurilor primare i formarea venei lienale poate varia mult de
la caz la caz; mai frecvent aceasta are loc la distana 3 5 cm de la hilul splinei, dar ntr-un ir de
cazuri aceast distan este neglijabil i constituie 0, 5 2 cm. n alte observri fuzionarea
venelor lienale extraviscerale poate avea loc la distana de 7 7, 5 cm de la splin.
n cazuri cnd trunchiul venei lienale este foarte scurt, este greu sau practic imposibil,
ca el s fie utilizat la formarea anastomozei spleno-renale n caz de insuficien portal. Condiii
mai bune pentru ndeplinirea operaiei de acest gen sunt create n cazurile cnd n regiunea
hilului splinei lipsesc venele de ordinul I II iar trunchiul gros al venei lienale i face apariia
din parenchimul splinei [14]. Lungimea venei lienale echivaleaz cu 8 12 cm; calibrul 6 12
mm. n majoritatea observaiilor trunchiul venei lienale i ramurile lui de ordinul I urmeaz de la
stnga spre dreapta, ntre foiele peritoneale ale ligamentului frenicolienal.
n unele cazuri, cnd coada pancreasului este situat foarte aproape de hilul splinei, venele trec
pe faa anterioar a cozii glandei. Apoi vena lienal trece prin incisura marginii superioare a
corpului pancreasului ntr-un anule, dup colul pancreasului, unde se unete cu vena
mesenteric superioar, formnd vena port. Traiectul venei lienale este rectiliniu cu formarea
unei curbe uoare.
Topografic pot fi evideniate 3 poriuni a venei lienale: proximal, mijlocie i distal.
n 66, 7 % din cazuri vena era de la nceput situat pe marginea superioar a corpului i cozii
pancreasului. Locull fuziunii ei cu vena mesenteric superioar era acoperit de colul pancreasului
parial sau complet. Sunt cazuri cnd vena trece mai jos de marginea superioar a glandei,
urmnd pe feele anterioar sau posterioar ale corpului pancreasului, iar porinea distal
corespunde mijlocului lungimii corpului pancreatic. Splina accesorie reprezint o malformaie
congenital ce se caracterizeaz prin esut splenic ectopic separat de corpul splinei [3]. Prezena
acestei malformaii a fost constatat n 10% 30% cazuri la necropsii i n 45% 65% cazuri
dup splenectomie [5].
Splina accesorie se dezvolt din cauza fuziunii incomplete a primordiilor
mezenchimale de dezvoltare a splinei, fiind n totdeauna localizate n partea stng a
abdomenului din cauza rotaiei splinei spre stngaa n timpul embriogenezei. Dimensiunile
splinei accesorii, de regul, variaz de la inluziuni mici microscopice pn la un diametru de 2-3
cm. Cele mai frecvente localizri ale splinei accesorii sunt hilul splinei (75%), coada
pancreasului (20%), artera splenic, ligamentele gastrosplenic, splenocolic i gastrocolic. Foarte
rar splinele accesorii pot fi localizate n mezou, ligamentul splenorenal, epiploon, peretele
jejunului, intrahepatic, sau n regiunea presacral, n scrot, mediastin. Splinele accesorii pot fi
solitare sau multiple, vascularizate cu ramuri ce pornesc de la artera splenic [3].
Fenomenul splinei accesorie a fost studiat pe un lot de 68 macropreparate (26 (38,
29, 53%) au fost de genul feminin i 42 (61, 87, 49%) de genul masculin (< 0,05). La femei
splina accesorie a fost depistat n 4 (22, 7%) cazuri, iar la brbai n 2 (4, 8%).
Preparatele luate de la femei n dependen de vrst au fost repartizate n felul
urmtor: 36-55 ani 26, 9% (7 cazuri), 56-74 ani 50, 0% (13 cazuri), iar n grupa 79-90 de ani
23, 1% (6 cazuri). Este necesar de menionat c splina accesorie (n = 4) a fost depistat numai
n grupa 56-74 ani.
ntre brbai cea mai mare parte din macropreparate 52, 4% (22 cazuri) sunt din
grupa de vrst 36-60 ani, ntre care 1 preparat cu splina accesorie. Partea pentru grupa de
vrst 61-74 ani constitue 19, 0 % (8 cazuri), din care 1 cu splina accesorie, i 16, 7% (7
cazuri) n grupa de vrst 75-90 ani.
n structura macropreparatelor de la brbai pn la vrsta 35 ani (5 cazuri): cte 2, 4%
- nou-nscuii i vrsta 17-21 ani, i 7, 1% n grupa de vrst 22-35 ani.
71
Concluzii
1.Splina este inervat de ctre nervii plexurilor lienal i pancreatic i vascularizat prin ramurile
arterei lienale.
2.Att structural, ct i topografic, artera lienal se evideniaz printr-o gam de variante. Ele se
refer la traseul ei extraorganic, precum i la arhitectonica sistemului vascular intravisceral.
Metoda macroscopic de disecare a demonstrat c traiectul rectiliniu al arterei lienale se
ntlnete mai frecvent 44,5% din cazuri, iar mai rar vasul respectiv era uor sinuos 33,4%
din cazuri.
3.Artera lienal mai frecvent este localizat pe marginea superioar a pancreasului (54,4% din
cazuri).
4. Prin rezultatele analizei panaortogramelor artera lienal era bifurcat n 54, 4% din cazuri.
5.n majoritatea cazurilor constitueni ai venei lienale sunt dou vene de ordinul I.
Bibliografie
1. Cougard P. Study of the vascular segmentation of the spleen. Bull. Assoc. Anat. (NANCY).
1984; 68 (200): 27-33.
2. Frippiat F., Donckier J., Vandenbossche P., Stoffel M., Boland B., Lambert M. Splenic
infraction: report of three cases of atherosclerotic embolization originating in the aorta and
retrospective study of 64 cases. Acta Clin Belg. 1996; 51: 395-402.
3. Impellizzeri P., Montalto A.S., Borruto F.A. et al. Accessory spleen torsion: rare cause of
acute abdomen in children and review of literature. J. Pediatr. Surg. 2009. 44:E15-E18.
4. Jonqueira L. C., Carneiro J. Basic histology, tenth edition, 1998.
5. Kim S.H., Lee J.M., Han J.J. et al. Intrapancreatic accessory spleen: findings on MR imaging,
CT, US and scintigraphy, and the pathologic analysis. Korean J. Radiol. 2008. 9:162-74.
6. Liu D.L., Xia X., Xu W., Ye O. Anatomy of vasculature of 850 spleen specimens and its
application in parial splenectomy. Surg. 1996. 119:27-33.
7. Nistor I., Taisescu O., Mndril I., Taisescu C. Observaii microanatomice asupra structurilor
colagenice din sistemele morfofuncionale splenice. Revista Romn de Anatomie funcional
i clinic, macro- i microscopic i de Antropologie. V. III, nr. 3, 2004, 136 139.
8. Pintilie D.-G., Zamfir M. Tipurile chirurgicale de arter splenic i influenele lor asupra
chirurgiei supramezocolice. Revista Romn de Anatomie funcional i clinic, macro- i
microscopic i de Antropologie. V.3, 1, 2004, 71-72.
9. Redmond H. P., Redmond J. M., Rooney B. P. et al. Surgical anatomy of the human spleen.
Br. J. Surg. 1989; 76: 198-201.
10. Sindel M., Sarikcioglu L. The importance of the anatomy of the splenic artery and its
branehes in splenic artery embolization. Folia Morphol. 2001; vol 60, N4, 333-336.
11. Skandalakis P.N., Colbom G.L., Skandalakis L.J. et al. The surgical anatomzy of the spleen.
Surg. Anat. and Embriol. 1993. 74(4):747-67.
12. Wilson-Okoh D. A., Nwauche C. A., Ejele O. A. Splenic changes in sickle cell anemia.
Nigerian journal of Medicine, vol. 15, 1, 2006, 20-23.
13. .., .. .
. . 2005, 10, c. 55-60.
14. . ., . . . ., 1970.
15. . . .
. 2006, 4, . 58.
16. . ., . ., . .
. .
. 2008, . 2, . 52-54.
17. . .
. . 1980. 8.C. 84 91.
73
NERVUL TERMINAL
(Revista literaturii)
Ion Artene
(Conductor tiinific : dr. conf. Teodor Lupacu)
Catedra Anatomia Omului USMF
Summary
The terminal nerve
The terminal nerve, also called ,, cranial nerve 0 , is the foremost cranial nerve. It looks
like a microscopic ,sympathetic nerve plexus ( J.F. Huber). The nerve is distributed in the
subarachnoid space which covers the gyrus rectus , and in the mucous membrane of the olfactory
area . The presence of the terminal nerve is a certitude, first stated by Dr. Johnston in 1913 and
further confirmed by other researchers .
Peripheral distribution and central connections of the nerve with the limbic system prove
its implication into the mechanism of olfaction in which has a modulatory role.
Rezumat
Nervus terminalis, numit i ,, nervul cranian zero , este cel mai anterior nerv cranian. El
apare sub forma unui plex nervos microscopic, simpatic (J.F. Huber), cu directie centrifugal de
propagare a impulsurilor, distribuit n spaiul subarahnoidian ce acoper girusul rect, precum i
n mucoasa ariei olfactive. Prezena nervului terminal la om este o certitudine, semnalat pentru
prima dat n anul 1913 de ctre Dr. Johnston, i ulterior reconfirmat de mai muli exploratori.
Distribuia periferic i conexiunile centrale ale nervului terminal cu sistemul limbic,
demonstreaz implicarea lui n mecanismele olfaciei n calitate de modulator.
Nervul terminal este mult mai fin dect restul nervilor cranieni, deaceea, n majoritatea
cazurilor, el este nlturat n timpul autopsiilor. Depistarea nervului, fr o coloraie special,
este foarte dificil din cauza dimensiunilor lui foarte mici (comparabile cu cele ale unui fascicul
de colagen) i fuzionarea acestuia cu filetele nervului olfactiv.
Cu toate c nervul terminal este foarte apropiat de nervul olfactiv i este de cele mai multe
ori confundat cu o ramur de-a acestuia, el are origine diferit i nu este conectat cu bulbul
olfactiv [5,9].
Datele raportate se bazeaz pe diseciile efectuate la fetui cu vrsta ncepnd cu 10
sptmni i la nou-nscui, precum i la persoane adulte. Nervus terminalis a fost identificat n
toate cazurile examinate.
Poriunea intracranian a nervului terminal, ncepe n regiunea trigonului olfactiv [6,15],
i se ntinde n direcie anterioar peste suprafaa medial a tractului i bulbului olfactiv, pe
suprafaa lateral a crestei de coco pentru ca mai apoi s abandoneze cavitatea craniului prin
orificiile anterioare ale lamei cribriforme. n cursul su peste suprafaa medial a tractului
olfactiv, nervul se prezint ca un fascicul de fibre nervoase condensate, mai nchise la culoare
dect fasciculele colagene ale meningelui cerebral. Pe faa medial a bulbului olfactiv, fasciculul
se ramific formnd un plex de fibre care se ntreptrund cu fila olfactoria. La nivelul punctelor
de ramificare ale plexului se formeaz civa microganglioni. Unul dintre acetea, format la
nivelul la care nervul terminal se ncrucieaz cu nervul vomeronazal, este mult mai mare dect
restul, fiind numit ganglionul terminal [6,9]. Plexul se extinde pe faa lateral a crestei de coco ,
implantat fiind n pahimeninge. n acest loc, filamentele separate ale plexului nervului terminal
sunt situate la o anumit distan ( variabil, dar corelat cu nlimea crestei de coco) deasupra
plcii cribriforme, spre deosebire de fila olfactoria care se plaseaz direct pe ea.
Dup ce n interiorul cavitii craniului nervul terminal ader la fila olfactoria i la nervii
vomeronazali, acesta trece n mucoasa nazal mpreun cu ei.
Majoritatea fibrelor plexului intracranian al nervului se reunesc ntr-un singur fascicul,
care iese din lama cribriform anterior de nervii vomeronazali. Fibrele regrupate n fascicul,
74
mai corect i alegerea metodei terapeutice adaptat perfect fiecarui caz se utilizeaza flebografia
i ultrasonografia Doppler pentru verificarea permeabilitii sistemului venos profund i
evaluarea venelor perforante.
Metodele terapeutice chirurgicale utilizate n tratamentul insuficienei venoase cronice sunt:
safenectomiile prin stripping, flebectomiile si crosectomiile, asociate cu tratament antiinflamator,
flebotonic etc. [2, 3, 8].
Muli pacieni supui unei operaii de stripping prezint o complicaie frecvent lezarea
nervului safen [1, 5, 9, 10, 16, 20, 21, 24]. Semnele lezrii nervului uneori persist pentru un
timp ndelungat i nu pot fi neglijate. n literatura de specialitate incidena lezrii nervului safen
dup un stripping total este destul de variabil, de la 6-7 % [10] pn la 58 % [16], iar efectul
acestei lezri asupra calitii vieii nu este adecvat studiat.
Dup Nair i coautorii [18] semnele lezrii nervului safen sunt prezente n 90 % cazuri ndat
dup stipping i persist n 10% cazuri peste 14 - 18 luni dup intervenie. Semnele acestei lezri
pot afecta calitatea vieii n 6,7 % din cazuri [16]. Manifestrile lezrii nervului safen sunt de
cele mai dese ori subiective, iar metode obiective de evaluare a acestei traumatizri nu au fost
stabilite, cu mici excepii [1].
Semnele lezrii nervului safen sunt: amoreal, furnicturi, dureri, anestezie. Localizarea
tipic a durerii este pe faa medial i inferioar a gambei. Alte simptome de asemenea prezente
sunt: hipoestezie, parastezie i hiperestezie.
S-a observat c strippingul selectiv a venei safene mari reduce incidena de traumare a
nervului safen [9, 20], dar un alt raport arat c nu este nici o diferen ntre strippingul total i
cel selectiv.
Ramasastry i coautorii [20] au demonstrat c strippingul n direcie cranial (disecia ncepe
de la maleola medial i continu cranial) este nsoit de schimbri senzitive semnificative n
teritoriul senzitiv al nervului safen pe parcursul a 12 sptmni postoperatorii consecutiv n
raport cu strippingul n direcie caudal (disecia ncepe cu jonciunea safenofemural i
continu caudal). La 6 luni de la stripping, ns, rezultatele erau similare. Dup un studiu efectuat
pe cadavre [20] autorii au concluzionat c n timpul strippingului n direcie cranial smulgerea
ramurii pretibiale i/sau ramurii infrapatelare se ntlnete mult mai frecvent dect n strippingul
n direcie caudal.
O metod, care ar elimina complicaia dat la moment nu a fost raportat, probabil, fiindc o
metod de evaluare obiectiv a lezrii nervoase nu a fost stabilit, iar simptomele traumrii
nervului safen sunt doar subiective.
Cunoaterea anatomiei nervului safen este un criteriu indispensabil pentru stabilirea unor
asocieri obiective ntre simptomatologia cu care se confrunt clinicienii n practic i substratul
morfologic.
Nervul safen este o ramur a nervului femoral, care la rndul su, este un nerv mixt, constituit
din unirea ramurilor anterioare ale nervilor spinali L2, L3 i L4 la nivelul bazinului ntre marginea
extern a psoasului i muchiului iliac.
Nervul femural merge sub ligamentul inghinal, lateral de vasele femurale i ajunge n
triunghiul Scarpa, unde se divide n numeroase ramuri care diverg n toate sensurile [12, 22, 27,
28]. El d ramuri colaterale i ramuri terminale [12, 13, 29].
Ramurile colaterale ale nervului femural apar pe traiectul intrapelvin a nervului i se distribuie
muchiului psoas mare, muchiului iliac i muchiului pectineu [12, 13] i o ramur pentru
artera femural [29].
Ramurile terminale prezint un teritoriu motor i altul senzitiv.
Teritoriul motor este reprezentat de ramurile musculare, ce se distribuie la muchii sartorius,
pectineu i adductor lung i cvadricepsului femural.
Teritoriul senzitiv este reprezentat de ramuri cutanate (rr. cutanei femoris anteriores) i
nervul safen (n. saphenus). Acetia inerveaz tegumentul prii anterioare a coapsei, prii
78
interne a genunchiului, tegumentul feei interne a gambei, regiunii maleolare, marginii mediale a
plantei pn la baza primului metatarsian [12, 22, 27, 29].
Dup ali autori [6, 12] nervul femoral se divide n 4 ramuri terminale, dispuse n dou
straturi, superficial (nervul musculo-cutanat extern i nervul musculo-cutanat intern) i profund
(nervul cvadricepsului i nervul safen):
nervul musculo-cutanat extern, care se distribuie muschiul croitor i senzitiv feei externe
a coapsei i interne a genunchiului;
nervul musculo-cutanat intern, ce inerveaz muchii pectineu i adductor lung i senzitiv
regiunea antero-intern a coapsei;
nervul cvadricepsului ce se divide n ramuri, pentru fiecare din cele patru poriuni
constituiente ale muchiului cvadriceps: vast medial, vast lateral, vast intermediar i
drept femoral;
nervul safen este, de fapt, o ramur senzitiv pentru faa medial a gambei i a regiunii
anterioare a rotulei.
Nervul musculo-cutanat extern este un nerv ce se divizeaz n ramuri musculare i cutanate.
Ramurile musculare n numr variabil sunt destinate muchiului croitor, iar cele cutanate sunt n
numr de trei: ramura perforant cutanat superioar, ramura perforant cutanat medie i
ramura cutanat accesorie a venei safene mari [6]. Ramura cutanat accesorie se divide n dou
ramuri secundare: una superficial, alta profund. Ramura superficial este ramura satelit a
venei safene interne, penetreaz muchiul croitor, nsoete vena safena mare pn la faa intern
a genunchiului. Ramura profund e ramura satelit a arterei femurale, nsoete artera pn n
canalul Hunter i se ramific pe faa intern a genunchiului. Cele dou subdiviziuni ale ramurii
cutanate accesorii anastamozeaz cu terminaiile sale cu ramura cutanat a nervului obturator i
nervul safen [6].
Nervul musculo-cutanat intern se divide de la originea sa n ramuri musculare i cutanate.
Ramurile musculare n numr variat de la 1 la 3, traverseaz oblic faa posterioar a vaselor
femurale i inerveaz muchiul pectineu i muchiul adductor lung. Ramurile cutanate sunt i
ele n numr variabil; cnd sunt dou ramuri, una trece anterior, a doua posterior de vasele
femurale, se unesc lateral de arter ntr-o ramur unic, traverseaz fascia lata i se ramific pe o
poriune mic n partea supero-intern a coapsei. O ramur care trece anterior de vase poate
exista singur [6].
Nervul cvadricepsului cedeaz patru ramuri, care sunt destinate celor patru pri ale
quadricepsului: rectului femoral, vastului lateral, vastului medial i vastului intermediar [6, 12].
Nervul safen este situat lateral de vasele femurale i este nsiit de nervul vastului medial. n
partea inferioar a triunghiului Scarpa nervul penetreaz teaca vaselor femurale, apoi descinde
de-a lungul arterei femurale pn la extremitatea inferioar a canalului Hunter. Pe traiectul su
nervul safen se plaseaz succesiv n faa, apoi n spatele arterei. Nervul safen traverseaz lamela
fibroas vastoadductorie a canalului Hunter, poate singur, sau poate nsoit de ramura
descendent a genunchiului de la artera femural. Dup ce perforeaz fascia coapsei se mparte
n ramuri terminale: ramura rotulian (infrapatelar) i ramura crural sau ramura cutanat
medial a gambei.
Ramura infrapatelar sau rotulian cedeaz numeroase ramificaii divergente pe faa
anterioar a genunchiului; cnd ncepe foarte nalt de la nervul safen, devine superficial,
perfornd muchiul croitor i constituie a treia ramur perforant sau ramura cutanat perforant
inferioar [6, 12].
Ramura crural nsoete vena safena mare i se distribuie ntr-un numr de ramuri cutanate
pe faa intern a gambei. Raporturile dintre vena safena mare i nervul safen sunt foarete variate,
aceste dou structuri fiind situate foarte aproape una de alta, iar cunotinele despre anatomia lor
sunt insuficiente pentru a preveni lezarea nervului [11, 19]. Vena safena mare trece de-a lungul
nervului safen n 59,5 % cazuri n treimea medie a gambei i 83,1 % n treimea inferioar a
79
gambei [17]. n mai mult de 50 % cazuri s-a demonstrat c perineurium nervului safen este fixat
de adventiia venei [17]. Ramura crural se termin pe faa antero-intern a gleznei, maleolei
mediale i marginea medial a piciorului.
Lezarea nervului safen este urmat de tulburrile de sensibilitate obiectiv, limitndu-se la
teritoriul senzitiv inervat, anestezia interesnd faa intern a gambei.
Cunoaterea interrelaiilor dintre nervul safen i vena safena mare ar putea reduce incidena
lezrii nervului intraoperator.
Bibliografie
1. Akagi D., Arita H., Komiyama T. Objective assesment of nerve injury after greater
saphenous vein stripping. European Journal of Vascular and Endovascular Surgery, 2007,
vol. 33, p. 625-630.
2. Avram J. Clasic i endoscopic n chirurgia venelor perforante. Ed. Hestia,Timioara, 2000.
3. Bucur G. Flebologie practic medical i dermatologic. Ed. Infomedica Bucureti, 2002.
4. Casian D., Guu E., Cazacu A., Zaporojan A. Rolul ultrasonografiei duplex ca metod de
baz naintea revascularizrii membrelor inferioare. Arta Medica, N4 (25), Chiinu, 2007,
p.14-15
5. Chauhan BM, Kim DJ, Wainapel SF. Saphenous neuropathy following cardiac surgery. NY
State Journal of Medicine, 1981, vol. 2, p. 222223.
6. Chevrel J.P. Anatomie Clinique. Les membres, tome 1, Springer Verlag, Paris, 1991, p.
387-388, p. 443.
7. Coma F. Cercetri histologice, histochimice i electronomicroscopice n venele varicose.
Rezumatul tezei de doctorat Iai, 2010.
8. Conu O., Tabac D., Bernaz E. Principii de tratament i reabilitare a pacienilor cu tromboza
venelor profunde a membrelor inferioare. Arta Medica, N1 (16), Chiinu, 2006, p. 30-32.
9. Cox S. J, Wellwood J.M., Martin A. Saphenous nerve injury caused by stripping of the long
saphenous vein. British medical journal, 1974, vol. 1, Issue 5905, p. 415-417
10. Flu HC, Breslau PJ, Hamming JF, Lardenoye JW. A prospective study of incidence of
saphenous nerve injury after total great saphenous vein stripping. Dermatologic Surgery,
2008, vol. 34, p.1333-1339.
11. Holme JB, Holme K, Sorensen LS. The anatomic relationship between the long saphenous
vein and the saphenous nerve. Acta Chirurgica Scandinavica, 1988, vol. 154, p. 631633.
12. Ifrim M., Niculescu G. Compendiu de anatomie, Bucureti, 1988, p. 172-173.
13. Kahle W., Leonhardt H., Platzer W. Anatomie. Systeme nerveux et organes de sens, tome 3,
Flammarion Medecine Sciences, Paris, 12e tirage, 1998, p. 82-83.
14. Labropoulos N., Leon Jr L.R. Duplex evaluation of venous insufficiency. Seminars in
Vascular Surgery, 2005, vol. 18, p. 5-9.
15. Lsi M., Zmuncil V., Samsonov A., Sajin A., iganu V., Rotaru A. Aspecte de diagnostic
i tratament n flebotromboze. Arta Medica, N4 (25), Chiinu, 2007, p. 17.
16. Morrison C, Dalsing MC. Signs and symptoms of saphenous nerve injury after greater
saphenous vein stripping: prevalence, severity, and relevance for modern practice. Journal of
Vascular Surgery, 2003 Nov, vol. 38(5), p. 886-890.
17. Murakami G, Negishi N, Tanaka K, Hoshi H, Sezai Y. Anatomical relationship between
saphenous vein and cutaneous nerves. Okajimas Folia Anatomica Japonica, 1994 May, vol.
71(1), p. 21-33.
18. Nair UR, Griffiths G, Lawson RAM. Postoperative neuralgia in the leg after saphenous vein
coronary artery bypass graft. Thorax, 1988, vol. 43, p. 4143.
19. Price C. The anatomy of the saphenous nerve in the lower leg with particular reference to its
relationship to the long saphenous vein. Journal of Cardiovascular Surgery, 1990, vol. 31, p.
294297.
20. Ramasastry SS, Gregory OD, Futrell JW. Anatomy of the saphenous nerve: relevance to the
saphenous vein stripping. American Surgeon, 1987, vol. 53, p. 274277.
80
21. Sorrentino P., Renier M., Coppa F., Sarzo G., Morbin T., Scappin S., Baccaglini U.,
Ancona E. How to prevent saphenous nerve injury. A personal modified technique for the
stripping of the long saphenous vein. Minerva Chirurgica, 2003, vol. 58, Issue 1, p. 123-128.
22. tefane M. Anatomia omului, Chiinu, 2010, vol. 3, p. 238.
23. Tabac D., Castrave A., urcanu A., Ghiu V., Iachim V., Bernaz E. Problemele flebologiei
chirurgicale la etapa actual. Rezumatul lucrrilor Congresului al IX lea al asociaiei
Chirurgilor N. Anestiadi, I Congres de Endoscopie din Republica Moldova, Chiinu,
2003, p. 93.
24. Wood JJ, Chant H, Laugharne M, Chant T, Mitchell DC. A prospective study of cutaneous
nerve injury following long saphenous vein surgery. European Journal of Vascular and
Endovascular Surgery, 2005, vol. 30, p. 654-658.
25. Zaporojan A., Casian D., Moroz S., Culiuc V. Flebotrombozele acute iliofemorale. Arta
Medica, N4 (25), Chiinu, 2007, p. 18.
26. Znoag M., Spnu A., Mutavci Gh., Ciobanu M., Popa V. Unele aspecte de diagnostic i
tratament chirurgical al sindromului posttromboflebitic la membrele inferioare. Arta Medica,
N4 (25), Chiinu, 2007, p. 18-19.
27. . ., .., .. ,
, 1985, . 554.
28. .. , , 1987, 2.
29. .. , , 1974, 3, .
235-236.
Minimum
11.0 mm
6.1 mm
7.1 mm
Maximum
24.5 mm
14.8 mm
19.8 mm
Tab. 2. The mean distance between the origin of the aortic arch branches
The mean distance between
BT - LCC
LCC- LS
Minimum
0,1 cm
0,3 cm
Maximum
0,5 cm
2.0 cm
The anomalous origins of the branches of the AA is attributed to the altered development of
certain brachial arch arteries during the embryonic period of gestation.
The AA in two specimens of the above group (2%) had only 2 great branches. They
originated from the upper convex surface of the aortic arch. The first was a common trunk,
which incorporated the BT and the LCC. The second was the LS, which arose independently
distal to the origin of the common trunk (fig.2 ).
82
Conclusions
In conclusion, the different branching patterns of the AA observed in this study and the
morphometric measurements taken can assist surgeons in performing safe and effective surgeries
in the superior mediastinum.
With the ever increasing complex endovascular interventions in the aorta and head and neck
regions, recognition and appreciation of these entities is of importance to the interventional and
diagnostic radiologist alike.
83
1.
2.
3.
4.
5.
Bibliography
Bhatia K, Ghabriel MN, Henneberg M. Anatomical variations in the branches the human
aortic arch: a recent study of a South Australian population. Folia Morphol (Warsz) 2005;
64(3): 217-223.
Goray VB, Joshi AR, Garg A, Merchant S, Yadav B, Maheshwari P. Aortic arch variation: a
unique case with anomalous origin of both vertebral arteries as additional branches of the
aortic arch distal to left subclavian artery. AJNR Am J Neuroradiol 2005; 26(1): 93-95.
Lippert H, Pabst R. Aortic arch. In: Arterial Variations in Man: Classification and Frequency.
Munich, Germany: JF Bergmann-Verlag, 1985. 310.
Nayak SR, Pai MM, Prabhu LV, DCosta S, Shetty P. Anatomical organization of aortic arch
variations in the India: embryological basis and review. J Vasc Bras 2006; 5(2): 95-100.
Shin Y, Chung Y, Shin W, Im S, Hwang S, Kim B. A morphometric study on cadaveric aortic
arch and its major branches in 25 Korean adults: the perspective of endovascular surgery. J
Korean Neurosurg Soc 2008; 44(2): 78-83.
84
Right side
16,72 mm
14,21 mm
Posteriorly 0,54 mm
22,41 mm
30,56 mm
32,8
Left side
16,78 mm
14,41 mm
Posteriorly 0,63 mm
22,23 mm
29,83 mm
32,05
In order to determine the position of the mental foramen in relation to the anterior and
posterior borders of the mandible a horizontal line was drawn from the most proeminent point of
the mandible symphysis to the posterior border of the ramus of the mandible. The following
distances were measured (tab.4):
1) from the most proeminent point of the mandibular symphysis to the anterior border of the
MeF;
2) from the posterior border of the MeF to the posterior border of the mandible;
3) from the inferior border of the mandible to the inferior border of the MeF.
There was no significant variation of the shape of the MF. The mental foramen may be round
or oval (60,15%) in shape, it may be absent, unilateral or bilateral and in some cases may be
multiple on one or both sides of the mandible. Its diameter is 3-7 mm.
Comparison of the study results with the other studies
Table 2 - Position of the mental foramen
Prabodha et al.
Study results
Mean distance from
Mandibular symphysis
26.52 mm
27,14 mm
Posterior border of the ramus of the mandible
65.38 mm
64,72 mm
Inferior border of the body of the mandible
12.25 mm
13,83 mm
Table 3 - Shape of the mental foramen
Shape
Mbajiorgu et al.
Gershenson et al.
Oval
56.3%
65.52%
Round
43.8%
34.48%
Prabodha et al.
66.67%
33.33%
Study results
60,15%
39,85%
In an adult with the advancement of the age MF was moved towards the superior border of
the body of the mandible (fig. .). This is mainly because of the loss of teeth and alveolar bone
resorption. There is a significant variation of the position of the MF with age. This is also
compatible with Prabodha et al. study.
Simple percentage evaluation was used to determine the frequency of the mental foramen in
relation to the lower teeth. In 50% of cases it is located at the adge of the second premolar root,
in 25% it is between the first and second premolars and 25% it is behind the second premolar.
It is important to report on the risk of anatomical variation of mental foramina, in order to
avoid nerve damage in connection with surgical procedures. The absence and variation of
accessory mental foramina has been reported in dry
human mandibles and on radiographs previously, and
can range from (0.2%) to (10.6%) on one side. A
double mental foramen in our study appears in
approximately 1% on the left side and in 1.1% on the
right side of the mandible .
Gershenson et al. (1986) who examined 525 dry
mandibles focusing on variation, shape and site
of the mental foramen related to the teeth, reported
that 4.3% mandibles had double mental foramina, and
0.7% mandibles had triple mental foramina. Finally
they found one mandible that had four mental foramina
on one side (0.1%).
Katakami et el. (2008) examined 150 patients Fig. 2. Photograph of the anterior
retrospectively with limited cone-beam computed surface of the mandible two
tomography and depicted 16 double foramina (10.6%) accessory mental foramina on the
right side.
and triple mental foramina on one side (0.6%).
87
The location of the mental foramen in relation to the mandibular teeth was assessed in the
dentate mandible. The location of the mental foramen is an important factor when considering
the mental and incisive anesthetic block and surgeries in the outer premolar mandibular region.
The present study shows the location in line with the long axes of the second premolar as the
most common position of the mental foramen, followed by the position between the first
premolars. In the present study this parameter is not influenced by gender.
Mental foramen was often observed in the apical of second premolar, while the accessory
mental foramen was detected between apical of second premolar and first molar or between
apical of canine and lateral incisor.
In most cases mental foramen of adult dentate mandible is located halfway between the
lower border of mandible and alveolary crest in a vertical line with the supraorbital notch.
The retromolar foramen (RMF) was found to occur in forth of 37 adult human mandibles
studied (10.7%). No statistically significant difference was found between left and right sides or
between sexes.
Additional foramina are clinically important as they can lead to diagnostic and therapeutic
misinterpretations.
Conclusions
1) The location and configuration of the mandibular canal is variable and should be carefully
observed using cross-sectional images of the mandibular canal and images perpendicular to
them when conducting surgical procedures such as implant treatment involving the mandible.
2) A number of studies have shown: a) variability of distance between the MF and mandibular
notch; b) difference in the position of the mental foramen in relation to the second premolar
and to the alveolary crest; c) the presence of additional mandibular, mental and retromollar
foramina.
References
1. Agthong S, Huanmanop T, Chentanez V. Anatomical variation of the supraorbital,
infraorbital, and mental foramina related to gender and side. J Oral Maxillofac Surg 2005;
63:800-4.
2. Ajit Auluck, Ausaf Ahsan, Keerthilatha M. Pai, Chandrakant Shetty. Anatomical variations
in developing mandibular nerve canal: a report of three cases. Neuroanatomy (2005) 4: 28
30.
3. Anwar Ramadhan, Elias Messo, Jan-Michal Hirsch Anatomical Variation of Mental
Foramen. A case report. Stomatologija, Baltic Dental and maxillofacial Journal, 12: 93-6,
2010.
4. Ayla Ozturk, Anitha Potluri, Alexandre R. Vieira. Position and course of the mandibular
canal in skulls. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Volume
113, Issue 4, April 2012, Pages 453458.
5. Greenstein G, Tarnow D. The mental foramen and nerve: clinical and anatomical factors
related to dental implant placement: a literature review. J Periodontol. 2006;77:1933 43.
6. Hasan Tabinda, Fauzi Mahmood, Hasan Deeba. Bilateral absence of mental foramen a
rare variation. International Journal of Anatomical Variations (2010) 3: 167169.
7. Igarashi C, Kobayashi K, Yamamoto A, Morita Y, Tanaka M. Double mental foramina of
the mandible on computed tomography images: a case report. Oral Radiol. 2004;20:68 71.
8. Phillips JL, Weller RN, Kulild JC. The mental foramen: 3size and position on panoramic
radiographs. J Endod 1992;18:383 6.
9. Sawyer DR, Kiely ML, Pyle MA. The frequency of accessory mental foramina in four
ethnic groups. Arch Oral Biol 1998;43:41720.
10. Marzola Clvis et al. Mandibular foramen contribution to your localization to the
anesthetical techniques. Revista ATO, 2004: 652 -678.
11. Miloglu Ozkan, Ahmet Berhan Yilmaz, Fatma Caglayan. Bilateral bifid mandibular canal:
88
A case report . Med Oral Patol Oral Cir Bucal. 2009 May 1;14 (5):E244-6.
12. Naitoh M, Hiraiwa Y, Aimiya H, Gotoh K, Ariji E. Accessory mental foramen assessment
using cone-beam computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2009;107:289-94.
13. Naitoh M, Hiraiwa Y, Aimiya H, Gotoh M, Ariji Y, Izumi M, et al. Bifid mandibular canal
in Japanese. Implant Dent. 2007;16:24-32.
14. Nortj C.J., Farman A.G., Grotepass F.W. Variations in the normal anatomy of the
inferior dental (mandibular) canal: A retrospective study of panoramic radiographs from
3612 routine dental patients. British Journal of Oral Surgery, 1977, Volume 15, Issue 1 ,
Pages 55-63.
portions of the respiratory and digestive tracts. At birth, the skull is large in comparison to the
rest of the body, and a baby's skull is compressible. A human skull is almost full sized at birth.
However the 8 bones that make up the cranium are not yet fused together. This means that the
skull can flex and deform during birth, making it easier to deliver a baby through the narrow
birth canal. The "soft spots" in a baby's head harden and grow together until the bones meet and
mesh like a jigsaw puzzle. The largest of the six main soft spots is a diamond-shaped area near
the middle of the top of the skull. This is the last area to harden and close, usually at about the
age of eighteen months.
The skull of the infant is markedly different from that of the adult. At birth the face is quite
small and undeveloped, while the cranium is relatively large. The frontal and parietal eminences
are very marked. The vault of the skull is not entirely ossified and the sutures are not completed.
The bones of the base of the skull originate in cartilage, while those of the vault originate in
membrane. This membrane has one or more centres of ossification appearing in it for each bone.
These centres increase in size and finally meet at the edges of the bone, thus forming the sutures.
At the time of birth the sutures are represented by membrane, which joins the adjacent bony
edges. The frontal bone has two centres of ossification; one for each side. These form a suture in
the median line of the forehead which becomes obliterated in the course of the first or second
year. Traces of it in the shape of a groove or ridge can sometimes be seen or felt in the adult
skull.
The frontal eminences are far more marked in childhood than
later in life and give to children the prominent forehead. A similar
peculiarity is seen in the parietal bones, the parietal eminences
being quite prominent. On this account, they are often injured in
childbirth, sometimes being compressed by the obstetrical forceps,
and are frequently the seat of haematoma neonatorum. The cranial
bones not being firmly united allow of a certain amount of play or
even overlapping, thus facilitating the delivery of the head at birth.
At the juncture of the various bones there are six spaces called Fig. 1. The body of
fontanelles. Two, the anterior and posterior, are in the median line the mandible with
of the cranium, and four, the two anterolateral and two completely resorbed
posterolateral, are at the sides. The fontanelles are situated at the alveolary process.
four corners of the parietal bones.
The anterior fontanelle is the largest. It is diamond-shaped and formed by the frontal suture in
front, the interparietal behind, and the coronal at each side. It is usually closed by the end of the
second year, but may be delayed until the fourth. In rickets and malnutrition the fontanelles
remain open longer than would otherwise be the case.
The posterior fontanelle is formed by the juncture of
the parietal (sagittal) suture with the lambdoidal suture.
It is triangular in shape with the apex forward between
the two parietal bones, the sides passing down, one to
the right and the other to the left of the top of the
occipital bone.
The pliable head which allowed the child to safely
pass through the birth canal is also responsible for
enabling normal human development during the first 18
months of a child's life. During this period the brain
grows rapidly and the skull has to be flexible enough to
adapt to its growth. The natural development of the
Fig. 2. Mandible of the infant (A)
cranial and facial bones involves changes in skull shape,
and adult (B).
which is also accommodated by the lack of a
permanently fused skull. The permanent skull is fused between the ages of 20 months and two
years.
90
During an individual's life, the morphological changes undergone by the mandible are thought
to be influenced by the dental states and age of patient.
The mandible and also the associated maxillary alveolar process may be almost completely
resorbed in elderly edentulous patients (Fig.1).
Tab.1. How to know roughly the age of the mandible?
Age
At birth
At 4 years
Adult
Old age
Angle
About 170
(very obtuse)
About 145
(25 less)
About 120
(25 less)
About 145
like young age again
Mental foramen
Near the lower border
Alveolar border
No eruption of the teeth
Slightly higher in
position
Midway between the
upper and lower
borders
Near the upper border
(due to absorbtion of
the alveolar margin)
The funnel-shaped lip of the mandible in old age causes the prominent chin and leads to a
reduced height of the lower face. In old age, the mandible is shaped like a clasp and flattened so
that it looks similar to the mandible of a newborn.
Severe atrophy results in the mental foramen becoming relatively more superior and closer to
the upper edge of this clasp and no longer visible from the vestibule. Atrophy of the alveolar
process significantly reduces the distance from the mandibular canal to the upper edge of the
mandible so that in rare cases the inferior alveolar nerve is located directly underneath the
mucosa.
Male and female skulls also show
significant differences in structure (Fig.3). The
small bulge at the back of the head known as
the external occipital protuberance is usually
more pronounced in men. The male jawbone
or mandible is typically angular and squareshaped at the chin area, while the female
jawbone tends to be more rounded and
pointed. The brow ridges of men are often
more prominent than those of women. These
distinctions in cranial and facial features
underlie the basic difference between men's
and women's faces.
All dimensions of the female skull and
face are smaller compared to the male
features. The facial width is relatively larger in
women than in men. Resulting contours are
therefore more rounded in females, especially
in the orbital area, with more prominent malar
(cheek) bones and less prominent mandibular
(chin/jaw) angles.
Fig. 3. Sex differences of the skull.
In the upper part of the face, the forehead is
91
quite different, most noticeably women have less sloping mid-foreheads and the position of their
eyebrows is higher and has a stronger curvature.
In the middle part of the face, the angles of the nose differ substantially, especially at the tip
portion. Females generally have a more pointed, narrow, and vertically shortened less nasal
prominence than males.
Tab.2. Sex and gender differences of the skull
Cranium Feature
General size
Architecture
Supraorbital torus
Mastoid process
Occipital bone
Frontal eminence
Parietal eminence
Orbit
Forehead
Cheek bones
Mandible
Ramus of mandible
Symphysis and mental
eminence of mandible
Palate
Occipital condyles
Posterior part
Frontal Bone
Temporal Ridge
Bony superciliary arches
Mastoid process
Supraorbital margin
External occipital
protuberance
Nuchal crest
Nuchal line
Zygomatic process (cheek
bones)
Paranasal sinuses
Teeth
Cranium
Total skull
Male
Large
Rugged
Medium to large
Medium to large
Muscle lines and protuberance
marked
Small
Small
Squared, lower, relatively
smaller with rounded superior
margins
Steeper, less rounded
Heavier, more laterally arched
Larger and more robust, higher
symphysis, gonial angle less
then 125, gonial angle flares
and is sharply angled
Straight
Square
Female
Small
Smooth and gracile
Small to medium
Small to medium
Muscle lines are not marked
Large
Large
Rounded, higher, larger with
very sharp superior margins
Rounded and full, sometimes
infantile
Lighter, more compressed
Smaller and lighter, gonial
angle more then 125, gonial
angle does not flare as much
outward and sharply angled
Slanting
Rounded (generally) or pointed
92
Small
Crest usually not as
pronounced, does not continue
across to temporal lines
More vertical and rounded
Small
Absent/slight
Small (generally)
Sharp
Generally absent
In the lower part of the face the most dominant differences are found in the chin region, which
varies markedly between the male and female. The male chin is larger in every dimension, the
mandible symphysis (upper chin) is generally wide and vertically high, while the female is more
rounded, and the male mental eminence (point of the chin) tends to be square and the female
more pointed. The degree of perceived masculinity/femininity due to the chin can vary
tremendously.
Bishara et al. (1990) showed that dento-facial parameters are bound to ethnic origins.
Until the age of puberty there is little difference between the skull of the female and that of
the male. The skull of an adult female is, as a rule, lighter and smaller, and its cranial capacity
about 10 per cent. less than that of the male. Its walls are thinner and its muscular ridges less
strongly marked; the glabella, superciliary arches, and mastoid processes are less prominent, and
the corresponding air sinuses are small or rudimentary. The upper margin of the orbit is sharp,
the forehead vertical, the frontal and parietal eminences prominent, and the vault somewhat
flattened. The contour of the face is more rounded, the facial bones are smoother, and the
maxill and mandible and their contained teeth smaller. From what has been said it will be seen
that more of the infantile characteristics are retained in the skull of the adult female than in that
of the adult male. A well-marked male or female skull can easily be recognized as such, but in
some cases the respective characteristics are so indistinct that the determination of the sex may
be difficult or impossible.
We have found that there are the key skull differences between the female skull and the male
skull. First of all, the male cranial mass is more blocky and massive compared to the females
one which is more rounder and tapers at the top.
Secondly, the females brow ridge margin is sharper while the males one is rather rounded
and dull. Thirdly, the zygomatic bone is more pronounced on the male skull than on the female
skull.
The Mandible or the lower jaw is more rounded on the female skull while the male skull is
squared. Also, the male have a deeper cranial mass than the female dose. And, last but not leastthe superciliary arch of the male skull is more pronounced and larger than the female skull.
There is a number of differences in the structure and appearance of bones between individuals
of different races that can be observed and used in the establishment of a victims ethnic origin.
The majority of these differences are based in the skull.
Caucasian skull, or white European descended people have relatively no prognathism (or the
extension of the lower jaw) and relatively little projection of the alveolar ridge. Faces are
typically smaller, with a tear-shaped nasal cavity and tower-shaped nasal bones. The palate is
triangular and the skull has a sloping eye orbital formation. The forehead and cranium are
prominent.
Mongoloid skull, or Asian people have small to no extension of the lower jaw and the nasal
sill or dam, and an oval nasal cavity. The nasal bones are tent-shaped and the palate is horseshoeshaped. The eye orbital is rounded and non sloping, and the cranium is generally rounded.
Black, or Negroid skulls feature a broad and round nasal cavity and no dam or nasal sill.
There is notable facial projection in the jaw and mouth area and a rectangular palate. The eye
orbit shape is square or rectangular. The skull is dolichocephalic, which means longer from front
to back proportionally.
In general, the racial group to which the person belongs is determined by examining the width
and height of the nose. It is important to note that many of these characteristics only have a
higher frequency among particular races and the presence or absence of one or more does not
automatically classify an individual into a racial group. Different human populations have
developed close proximity to one another due to mixed ethnic heritage.
93
Nasal Cavity
Prognathism
Eye Orbit
Mouth and
teeth
Zygomatic
bones
Conclusions
Knowledge of the large variability of the human skull is needed to dentists, pediatricians,
specialists of forensic services for the proper implementation of the anesthesia and plastic surgery,
assessment of child development, and for the establishment of a victims origin.
Bibliography
1. Fabian F.M., Mpembeni R. Sexual dimorphism in the mandibles of a homogenius black
population of Tanzania Tanz. J. Sci. Vol. 28(2) 2002: 47-54
2. Gldner C, Zimmermann AP, Diogo I, Werner JA, Teymoortash A.. Age-dependent
differences of the anterior skull base. Int J Pediatr Otorhinolaryngol. 2012 Jun;76(6):822-8.
Epub 2012 Mar 23.
3. Gwilym G. Davis. "Applied Anatomy: The Construction Of The Human Body", 1913.
4. Krzypow A.B., Orth D., Lieberman M.A., Michaela Modan, M.Sc.. Tooth, face,
and skull dimensions in different ethnic groups in Israel American Journal of Orthodontics,
1974, Volume 65, Issue 3, Pages 246249
5. Luiz Airton Saavedra de Paiva and Marco Segre Sexing the human skull through the mastoid
process. Rev. Hosp. Clin. Fac. Med. , 2003, S. Paulo, 58(1):15-20.
6. Rushton J. Philippe Sex and race differences in cranial capacity from international labour
office data. Intelligence, Volume 19, Issue 3, 1994, Pages 28129.
7. Susanne Gh., Assunta Gwidetti, Houspie R.. Age changes of skull dimensions. Anthrop. Anz.,
Stuttgart, 1985, Jg. 43, 1, 31-36.
94
extends from the top of the posteromedial septum across the ventricular cavity to the
anterolateral ventricular wall and separates the left ventricular cavity into an inflow and an
outflow tract.
The funnel-shaped inflow tract, which is formed by the mitral annulus and by both mitral
leaflets and their chordae tendineae, directs the entering atrial blood inferiorly, anteriorly, and to
the left.
The outflow tract, surrounded by the inferior surface of the anteromedial mitral leaflet, the
ventricular septum, and the left ventricular free wall, orients the blood flow from left ventricular
apex to the right and superiorly at an angle of 90 to the inflow tract.
With the onset of ventricular systole, both mitral leaflets are propelled together and upward,
converting the entire left ventricle into an expulsion chamber. The apical portion of the left
ventricle is characterized by fine trabeculations.
The anterior cusp protects approximately two-thirds of the valve. Note that although the
anterior leaflet takes up a larger part of the ring and rises higher, the posterior leaflet has a larger
surface area. These valve leaflets are prevented from prolapsing into the left atrium by the action
of tendons attached to the posterior surface of the valve, chordae tendineae.
Chordae Tendineae
Strong cords of fibrous tissue, the chordae tendineae, spring from the tip of each papillary
muscle. They often subdivide and interconnect before they attach to the two leaflets directly
above. The chordae may attach directly into a fibrous band running along the free edge of the
valves or they may become incorporated into the ventricular surface of the leaflet a few
millimeters back from the edge. Additional chordae run directly from the ventricular wall into
the undersurface of the posterolateral leaflet of the left ventricle.
The chordae tendineae, by their attachments to most of the free valvular border and by their
numerous cross connections, allow the valve leaflets to balloon upward and against each other
and evenly distribute the forces of ventricular systole. Dysfunction or rupture of a papillary
muscle or rupture of a chorda tendinea may undermine the support of one or more valve leaflets,
producing regurgitation.
The posterior leaflet, in contrast, is attached to more than half the circumference but is less
tall , and occupies only about the same area as the anterior leaflet. Moreover, the posterior leaflet
has a characteristic scalloped contour. In the usual case three scallops can be distinguished
divided by clefts. These scallops are termed posteromedial, middle and anterolateral.
The large the variation in the number of scallops exists. In 15% of cases 4-6 scallops being
seen in otherwise normal valves were found, in 3% two scallops only.
The mitral valve leaflets are supported by two
papillary muscles situated underneath the
commissural areas in the posteromedial and
anterolateral positions. Their position is such that
the chordae between muscle and leaflet operate at
the maximal mechanical efficiency. Each
papillary muscle supports the adjacent part of both
valve leaflets.
Papillary muscles
The papillary muscles are located below the
commissures of the AV valves. These muscles
project from the trabeculae carneae. In the left
ventricle the two groups of papillary muscles,
located below the anterolateral and posteromedial
commissures, arise from the junction of the apical
Fig.2. Fan-like papillary muscles.
and middle third of the ventricular wall. The
96
papillary muscles, because of their relatively parallel alignment to the ventricular wall and their
chordal attachments to two adjacent valve leaflets, pull the leaflets of the valve together and
downward at the onset of isovolumic ventricular contraction.
There is considerable variation in the morphology of the papillary muscles themselves,
particularly the posteromedial muscle (Fig.2). They may be single pillar-like muscles, bifid or be
composed of several heads of different size (fan-like papillary muscles). The different papillary
muscle architecture affects the chordal distribution (vide infra) and also affects the mode of the
arterial supply to the papillary muscle complex. Because of the different topography of the
anterior and the posterior leaflets, there are corresponding differences in the mode of chordal
support, which also show considerable individual variation.
The anterior leaflet is supported only by rough zone chordae together with the commissural
chords. The rough zone chords may be strengthened by thicker tendinous structures, the socalled strut chordae, usually one for each half of the leaflet. The commissural chords spring from
the tips of their papillary muscle and fan out to attach to the free margins of both leaflets. The
posteromedial commissural chord usually fans out more than that of the anterolateral
commissure.
As with the aortic valve, mitral valve closes some distance away from its free edge.
The inelastic chordae tendineae are attached at one end to the papillary muscles and the other
to the valve cusps. Papillary muscles are fingerlike projections from the wall of the left ventricle.
Chordae tendineae from each muscle are attached to both leaflets of the mitral valve. Thus, when
the left ventricle contracts, the intraventricular pressure forces the valve to close, while the
tendons keep the leaflets coapting together and prevent the valve from opening in the wrong
direction (thus preventing blood to flow back to the left atrium). Each chord has a different
thickness. The thinnest ones are attached to the free leaflet margin, whereas thickest ones are
attached quite away from the free margin. This disposition has important effects on systolic
stress distribution physiology.
The major chordae supporting a leaflet insert either into its free edge, or the area beyond the
free edge on the ventricular aspect up to the line of closure of the leaflet. This area between the
free edge and the line of closure is termed the rough zone in contradistinction to the area between
the line of closure and the basal attachment of the leaflet which is easily transilluminated and is
smooth. It is important to remember that the line of closure of a leaflet is not its free edge.
The major chordae supporting a leaflet insert either into its free edge, or the area beyond the
free edge on the ventricular aspect up to the line of closure of the leaflet. This area between the
free edge and the line of closure is termed the rough zone.
The chordae inserted into the rough zone are called rough zone chordae. They are
distinguished from basal chordae which pass from the ventricular myocardium to the ventricular
aspect of the leaflet close to its attachment and commissural chordae which are the discrete fanshaped chordae inserting into the free margin of the leaflet only and supporting two adjacent
leaflets.
Abnormalities of the mitral valve:
- Mitral Valve Prolapse: is when one or both valve flaps are enlarged. As a result, when the
heart pumps, the mitral valve flaps don't close smoothly and may not seal tightly. Instead, they
may collapse backward into the left atrium. This sometimes causes regurgitation.
- Mitral Valve Regurgitation: is when the mitral valve does not close well and blood leaks back
into the left atrium from the left ventricle. This causes the atrium to get bigger. Then it cannot
squeeze as effectively as it should.
- Mitral Valve Stenosis: is when the valve becomes narrow or tight. This makes it hard for the
blood to get through to the left ventricle. As a result, blood can back up in the blood vessels of
the lungs. Stenosis can also cause regurgitation.
The aortic semilunar valve is one of the valves of the heart. It is normally tricuspid (with
three leaflets), (in 1% of the population it is found to be congenitally bicuspid) . It lies between
the left ventricle and the aorta.
97
The semilunar aortic and pulmonary valves are similar in configuration, except the aortic
cusps are slightly thicker. Each valve is composed of the three fibrous cusps.
The U-shaped convex lower edges of each cusp are attached to and suspended from the root
of the aorta or pulmonary artery, with the upper free valve edges projecting into the lumen. The
cusps circle the inside of the vessel root.
Aortic semilunar valve consists of three equal-sized or nearly equal-sized semicircular cusps.
Each cusp is attached by its semicircular border to the wall of the aorta. The small space between
attachments of adjacent cusps is called a commissure. The semilunar valve has three
commissures. The three commissures lie equally spaced around the aorta, and the circumference
connecting these points has been termed the sinotubular junction, which may also be described
as the portion of the great vessel separating the sinuses of Valsalva from the adjacent tubular
portion of the great artery.
Each of the ventricular surfaces of the semilunar cusps has a small nodule (noduli Arantii) in
the center of the free edge marking the contact sites of closure. Behind each cusp the vessel wall
bulges outward, forming a pouchlike dilatation known as the sinus of Valsalva.
The free edge of each cusp is concave, with a nodular interruption at the center of the cusp,
the nodulus Arantii. The portion of the cusp adjacent to the rim is not as thick and may normally
contain small perforations (Fig.3).
Fig.3. Perforations of the right (a) and left (c) cusps of the aortic valve
During ventricular systole, the cusps are passively thrust upward away from the center of the
aortic lumen. During ventricular diastole, the cusps fall passively into the lumen of the vessel as
they support the column of blood above. The noduli Arantii meet in the center and contribute to
the support of the leaflets. The geometry of the cusps and the strong fibrous tissue support
provide excellent approximations of the cusps and prevent regurgitation of blood.
The aortic valve closes at some distance away from its free edge. The area between the line of
closure and the free edge in 15% of cases is fenestrated.
Abnormalities of aortic valve:
- Aortic stenosis: in which the valve fails to open fully, thereby obstructing blood flow out
from the heart.It can be caused as a result of rheumatic fever, degenerative calcification, and
congenital diseases such as bicuspid aortic valve.
- Aortic insufficiency, also called aortic regurgitation: in which the aortic valve is incompetent
and blood flows passively back to the heart in the wrong direction. It can be caused as a result of
aortic regurgitation include dilation of the aorta, previous rheumatic fever, infection,
i.e. infective endocarditis, myxomatous degeneration of the aortic valve, and Marfan's syndrome.
Bicuspid aortic valve: is the most common congenital abnormality of the heart, in this condition,
- instead of three cusps, the aortic valve has two cusps.
98
Conclusions
1. The valvular apparatus of the left heart shows the large individual variability.
2. A number of studies have shown: a) variability of size of the casps; b) variability of the
number of the chordae tendineae; c) difference in the position of the coronary foramina; d) the
presence of additional skullops; e) presence of clefts and perforations of the leaflets.
1.
2.
3.
4.
5.
Bibliography
Kasyanov V. A., B. A. Purinya B. A.and Ose V. P. . Structure and mechanical properties of
the human aortic valve. Mechanics of composite materials. Volume 20, Number
5 (1985), 637-647.
Nayar S., Nayar P.G., Kherian K.M.. Heart valve structure: a predisposing factor for
rheumatic heart disease. Heart, 2006, 92: 1151-1152.
Patil D., Mehta C., Prajapati P.. Morphology of Mitral valve in Human cadavers. The Internet
Journal of Cardiology. 2009 Volume 7, Number 2.
Robert B. Hinton and Katherine E. Yutzey. Heart Valve Structure and Function in
Development and Disease Annual Review of Physiology, 2011, Vol. 73: 29-46.
Thubrikar M., Nolan S.P., Bosher L.P., Deck J.D. The cyclic changes and structure of the
base of the aortic valve. Am Heart J 1980;99:217-24.
99